0001731122-20-001242.txt : 20201201 0001731122-20-001242.hdr.sgml : 20201201 20201201121002 ACCESSION NUMBER: 0001731122-20-001242 CONFORMED SUBMISSION TYPE: 10-Q/A PUBLIC DOCUMENT COUNT: 40 CONFORMED PERIOD OF REPORT: 20200930 FILED AS OF DATE: 20201201 DATE AS OF CHANGE: 20201201 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Intelligent Buying, Inc. CENTRAL INDEX KEY: 0001358633 STANDARD INDUSTRIAL CLASSIFICATION: RETAIL-COMPUTER & COMPUTER SOFTWARE STORES [5734] IRS NUMBER: 200956471 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-34861 FILM NUMBER: 201360309 BUSINESS ADDRESS: STREET 1: 340 MADISON AVENUE STREET 2: 19TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10173 BUSINESS PHONE: 646-202-2897 MAIL ADDRESS: STREET 1: 340 MADISON AVENUE STREET 2: 19TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10173 10-Q/A 1 e2251_10-qa.htm FORM 10-Q/A

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q/A

(Mark One)

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2020

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from __________ to __________

Commission File Number: 001-34861

INTELLIGENT BUYING, INC.

(Exact name of Registrant as specified in its charter)

California		20-0956471
(State of incorporation)		(I.R.S. Employer Identification No.)

340 Madison Avenue, 19th Floor

New York, New York 10173

(Address of principal executive offices) (zip code)

646-202-2897

(Registrant’s telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	☐	Accelerated filer	☐
Non-accelerated filer	☐	Smaller reporting company	☒
		Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act) Yes ☐ No ☒

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered

As of November 23, 2020, 7,254,588 shares of common stock, par value $0.001 per share, were issued and outstanding.

Explanatory Note

This amendment is being file to furnish the xbrl exhibits, no other changes were made.

INTELLIGENT BUYING, INC.

FORM 10-Q/A

September 30, 2020

TABLE OF CONTENTS

		Page No.
	PART I. - FINANCIAL INFORMATION
Item 1.	Financial Statements	1
	Consolidated Balance Sheets as of September 30, 2020 (Unaudited) and December 31, 2019	1
	Unaudited Consolidated Statements of Operations and Comprehensive Loss for the Three and Nine months Ended September 30, 2020 and 2019	2
	Unaudited Consolidated Statement of Changes in Stockholders’ Equity for the Nine months Ended September 30, 2020	3
	Unaudited Consolidated Statements of Cash Flows for the Nine months Ended September 30, 2020 and 2019	4
	Notes to Unaudited Consolidated Financial Statements	5
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	12
Item 3	Quantitative and Qualitative Disclosures About Market Risk	16
Item 4	Controls and Procedures	16

	PART II - OTHER INFORMATION

Item 1.	Legal Proceedings	17
Item 1A.	Risk Factors	17
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	17
Item 3.	Defaults upon Senior Securities	17
Item 4.	Mine Safety Disclosures	17
Item 5.	Other Information	17
Item 6.	Exhibits	18

FORWARD LOOKING STATEMENTS

This report contains forward-looking statements regarding our business, financial condition, results of operations and prospects. Words such as “expects,” “anticipates,” “intends,” “plans,” “believes,” “seeks,” “estimates” and similar expressions or variations of such words are intended to identify forward-looking statements, but are not deemed to represent an all-inclusive means of identifying forward-looking statements as denoted in this report. Additionally, statements concerning future matters are forward-looking statements.

Although forward-looking statements in this report reflect the good faith judgment of our management, such statements can only be based on facts and factors currently known by us. Consequently, forward-looking statements are inherently subject to risks and uncertainties and actual results and outcomes may differ materially from the results and outcomes discussed in or anticipated by the forward-looking statements. Factors that could cause or contribute to such differences in results and outcomes include, without limitation, those specifically addressed under the headings “Risks Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our annual report on Form 10-K, in “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in this Form 10-Q and information contained in other reports that we file with the SEC. You are urged not to place undue reliance on these forward-looking statements, which speak only as of the date of this report.

We file reports with the SEC. The SEC maintains a website (www.sec.gov) that contains reports, proxy and information statements, and other information regarding issuers that file electronically with the SEC, including us. You can also read and copy any materials we file with the SEC at the SEC’s Public Reference Room at 100 F Street, NE, Washington, DC 20549. You can obtain additional information about the operation of the Public Reference Room by calling the SEC at 1-800-SEC-0330 .

We undertake no obligation to revise or update any forward-looking statements in order to reflect any event or circumstance that may arise after the date of this report, except as required by law. Readers are urged to carefully review and consider the various disclosures made throughout the entirety of this quarterly report, which are designed to advise interested parties of the risks and factors that may affect our business, financial condition, results of operations and prospects.

Unless otherwise indicated, references in this report to “we,” “us” or the “Company” refer to Intelligent Buying, Inc. and its subsidiaries.

PART 1 - FINANCIAL INFORMATION

Item 1. Financial Statements.

INTELLIGENT BUYING, INC. AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS

(UNAUDITED)

	September 30, 2020			December 31, 2019
ASSETS
CURRENT ASSETS
Cash	$	1,834		$	9,024
Accounts Receivables		67,500			-
Loan Receivable		-			17,611
Investment		10,000			-
Advances to Supplier		134,874			123,000
Inventory		27,560			-
TOTAL CURRENT ASSETS		241,768			149,635

FIXED ASSETS (net of Depreciation)		38,058			2,546
OTHER ASSETS
Deposit		12,043			12,043
TOTAL ASSETS	$	291,869		$	164,224

LIABILITIES AND STOCKHOLDERS’ DEFICIENCY
CURRENT LIABILITIES
Accounts payable and accrued expenses	$	119,892		$	147,468
Loan payable – related party		220,805			240,803
Loan Payable – other		256,500			-
TOTAL CURRENT LIABILITIES		597,197			388,271
STOCKHOLDERS’ DEFICIENCY
Preferred Stock – Par Value of $0.001; 25,000,000 shares authorized; 1,000.000 and 0 shares issued and outstanding as of September 30, 2020 and December 31, 2019		1,000			-
Common Stock - Par Value of $0.001; 50,000,000 shares authorized; 7,254,588 and 7,975,003 shares issued and outstanding as of September 30, 2020 and December 31, 2019		7,254			7,975
Additional paid-in capital		1,376,884			905,604
Accumulated deficit		(1,690,466	)		(1,137,626	)
TOTAL STOCKHOLDERS’ DEFICIENCY		(305,328	)		(224,047	)
TOTAL LIABILITIES & STOCKHOLDERS’ DEFICIENCY	$	291,869		$	164,224

The accompanying notes are an integral part of these unaudited consolidated financial statements.

INTELLIGENT BUYING, INC. AND SUBSIDIARIES

UNAUDITED STATEMENTS OF OPERATIONS

	Three months ended September 30						Nine months ended September 30
	2020			2019			2020			2019

REVENUES:	$	166		$	-		$	19,219		$
TOTAL REVENUES		-			-

Cost of sales		-			-			9,509

Gross Profit		166			-			9,710			-

Operating Expenses
Advertising and Marketing		-						32,162
Selling Expenses		-						22,020
General and Administrative		5,323			5,690			134,544			19,459
Legal and Professional		11,400			7,000			289,711			32,758
Office rent		-						16,351
Management Fees		5,692			31,479			100,140			78,071
Product development cost								26,200

TOTAL OPERATING EXPENSES		22,415			44,169			621,128			130,288

LOSS FROM OPERATIONS		(22,249	)		(44,169	)		(611,418	)		(130,288	)

INCOME TAX PROVISION					-
Other Income (Expenses)								58,578
NET LOSS	$	(22,249	)	$	(44,169	)	$	(552,840	)	$	(130,288	)

NET LOSS PER COMMON SHARE – BASIC AND DILUTED	$	(0.003	)	$	(0.006	)		(0.077	)	$	(0.018	)

WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING		7,154,602			7,256,600			7,154,602			7,256,600

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

INTELLIGENT BUYING, INC. AND SUBSIDIARIES

UNAUDITED CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS’ DEFICIENCY

For the Nine Months Ended September 30, 2020

	Common Stock						Preferred Stock				Additional Paid in			Accumulated
	Shares			Amount			Shares		Amount		Capital			Deficit			Total
Balance December 31, 2019		7,975,003		$	7,975				$		$	905,604		$	(1,137,626	)	$	(224,047	)
Common stock issued
Share exchange		702,111			702			1,000,000		1,000		125,693						127,395
Issuance of common stock		2,532,200			2,532							397,468						400,000
Common stock cancelled		(4,114,353	)		(4,114	)						4,114						(0	)
Net loss for three months period															(362,673	)		(362,673	)
Balances March 31, 2020		7,094,961			7,095			1,000,000		1,000		1,432,879			(1,500,299	)		(59,325	)

Common stock issued		159,627			159													159
Adjustment to paid in capital												(55,995	)					(55,995	)
Net loss for three months period															(167,918	)		(167,918	)

Balances June 30, 2020		7,254,588			7,254			1,000,000		1,000		1,376,884			(1,668,217	)		(283,079	)
Net loss for the three months period															(22,249	)		(22,249	)
Balances September 30, 2020		7,254,588			7,254			1,000,000	$	1,000		1,376,884			(1,690,466	)		(305,328	)

Balance - December 31, 2018		7,256,600			7,257					-		759,761			(885,183	)		(118,165	)
Common stock issued
Net loss for three months ending March 31															(49,497	)		(49,497	)
Balances March 31, 2019		7,256,600		$	7,257			-		-	$	759,761			(934,680	)	$	(167,662	)

Common stock issued
Net loss for three months June 30, 2019															(36,622	)		(36,622	)
Balances June 30, 2019		7,256,600		$	7,257			-	$	-	$	759,761		$	(971,302	)	$	(204,284	)
Net Loss for three months September 30, 2019															(44,169	)		(44,169	)
		7,256,600		$	7,257			-		-	$	759,761		$	(1,015,471	)	$	(248,453	)

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

INTELLIGENT BUYING, INC. AND SUBSIDIARIES

UNAUDITED CONSOLIDATED STATEMENTS OF CASH FLOWS

	Nine Months ended
	September 30,
	2020			2019
OPERATING ACTIVITIES:
Net loss	$	(552,840	)	$	(130,288	)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation Expenses		3,765			255
Changes in operating assets and liabilities:
Accounts Receivables		(67,500	)
Inventory		(27,560	)
Loans receivables		7,611			(17,611	)
Advances to supplier		(11,874	)
Accounts payable and accrued expenses		(27,576	)		67,571
NET CASH USED IN OPERATING ACTIVITIES		(675,974	)		(80,073	)
INVESTMENT ACTIVITIES:
Purchase of office equipments		(39,277	)		(3,056	)
Deposit
NET CASH USED IN INVESTMENT ACTIVITIES		(39,277	)		(3,056	)
FINANCING ACTIVITIES:
Proceeds (Payment) of loan payable – other		(19,999	)		30,000
Proceeds from short term loan		256,500			-
Net proceeds from issuance of common stock		471,560
NET CASH PROVIDED BY FINANCING ACTIVITIES		708,061			30,000
INCREASE (DECREASE) IN CASH		(7,190	)		(53,129	)

CASH-BEGINNING OF PERIOD		9,024			53,129
CASH-END OF PERIOD	$	1,834		$	-
Supplemental disclosures of cash flow information:
Cash paid during the year for:
Interest	$			$	-
Taxes	$			$

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

INTELLIGENT BUYING, INC. AND SUBSIDIARIES

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2020

NOTE 1 – ORGANIZATION AND NATURE OF OPERATIONS

On February 14, 2020 (the “Closing Date”), we entered into and closed (the “Closing”) an Agreement and Plan of Reorganization (the “Agreement”) with Cannavolve and each of the 37 shareholders of Cannavolve who executed a counterpart signature to the Agreement (the “Cannavolve Shareholders”). Pursuant to the Agreement, the Company agreed to acquire an aggregate of 33,674,262 shares of common stock of Cannavolve constituting 81.5% of the issued and outstanding shares of common stock of Cannavolve from the Cannavolve Shareholders in exchange for 702,111 shares of common stock of the Company, constituting 9.6% of the issued and outstanding shares of common stock, $0.001 par value per share (the “Common Stock”), of the Company (the “Reorganization “). Pursuant to the Agreement, the Company agreed to file a Certificate of Determination with the State of California, as soon as practicable after the Closing, to create a new class of preferred stock of the Company, the Series B Preferred Stock (the “New Preferred”), and further agreed to issue, as a post-Closing covenant, 1,000,000 shares of the New Preferred to Principal Holdings, LLC (“Principal”), in consideration of Principal successfully negotiating the Agreement and performing due-diligence in connection with the Agreement. Additionally, pursuant to the Agreement, the parties agreed that the Company’s then principal shareholder, Bagel Hole Inc. (“Bagel Hole”), which is owned solely by Philip Romanzi, the Company’s Chief Executive, Chief Financial Officer, Treasurer, Secretary and sole director, would return to the Company for cancellation and retirement an aggregate of 4,114,352 shares of Common Stock owned by Bagel Hole. Additionally, pursuant to the Agreement, the parties agreed that at Closing, (i) Mr. Romanzi would resign from all executive officer and director positions with the Company, (ii) George Furlan would be appointed as the Company’s Interim Chief Executive Officer, Interim Chief Financial Officer, Interim Treasurer, Interim Secretary and Chief Operating Officer, and (iii) Dante Jones would be appointed as the Company’s sole director. Further, the parties agreed that two additional directors would be appointed to the Company’s board of directors after Closing.

At Closing pursuant to the Agreement: (i) we issued an aggregate of 702,111 shares of Common Stock to the Cannavolve Shareholders in exchange for 33,674,262 shares of Cannavolve common stock, constituting 81.5% of the issued and outstanding shares of Cannavolve, resulting in Cannavolve becoming our 81.5% owned subsidiary; (ii) Bagel Hole returned to INTB for cancellation and retirement 4,114,352 shares of Common Stock owned by Bagel Hole; (iii) Mr. Romanzi resigned from all officer and director positions with the Company; (iv) George Furlan was appointed as the Company’s Interim Chief Executive Officer, Interim Chief Financial Officer, Interim Treasurer, Interim Secretary and Chief Operating Officer; and (v) Dante Jones was appointed as the Company’s sole director. We anticipate that, in the near future, the size of the Board will be increased to three directors.

In addition, on May 28, 2020, the Company entered into and closed a Share Exchange Agreement (the “Share Exchange Agreement”) with the remaining shareholders of Cannavolve (the “Remaining Cannavolve Shareholders”). Pursuant to the Share Exchange Agreement, the Company acquired an aggregate of 7,656,441 shares of common stock of Cannavolve constituting 18.5% of the issued and outstanding shares of common stock of Cannavolve from the Remaining Cannavolve Shareholders in exchange for 159,627 shares of common stock of the Company, constituting 0.02% of the issued and outstanding shares of Common Stock of the Company and 1,000,000 shares of newly created Series B preferred stock (the “Share Exchange”). As a result of the Share Exchange, Cannavolve is a wholly owned operating subsidiary of the Company. Additionally, on May 28, 2020, the Company’s Board of Directors (the “Board) increased the size of the Board from one to two and George Furlan was appointed as a director to fill the vacancy.

The offers, sales, and issuances of the securities described above were deemed to be exempt from registration under the Securities Act in reliance on Section 4(a)(2) of the Securities Act of 1933, as amended and/or Rule 506 as promulgated under Regulation D as transactions by an issuer not involving a public offering. The recipients of securities in each of these transactions acquired the securities for investment only and not with a view to or for sale in connection with any distribution thereof and appropriate legends were affixed to the securities issued in these transactions. Each of the recipients of securities in these transactions was an accredited or sophisticated person and had adequate access, through employment, business or other relationships, to information about us.

On July 14, 2020, shareholders holding a majority of the Company’s outstanding voting stock voted in favor of the following corporate matters (the “Corporate Matters”) which relate to the approval to authorize (1) the amendment to the Company’s Restated Articles of Incorporation to effect a forward stock split of all of the outstanding shares of common stock of the Company at a ratio of seven for one (7:1) (the “Forward Split”), which such Forward Split will not impact the Company’s authorized shares of Common Stock, (2) the amendment to the Company’s Restated Articles of Incorporation to increase in the number of authorized shares of the Company’s Common Stock from 50,000,000 to 500,000,000 shares of common stock, (3) the amendment to the Company’s Restated Articles of Incorporation to effect a change of the Company’s name from Intelligent Buying, Inc. to Sentient Brands Holdings, Inc., and (4) changing the Company’s corporate domicile from California to Nevada. The Corporate Matters are not yet effective.

Cannavolve

Cannavolve was incorporated in the state of Washington on July 6, 2012. To date, Cannavolve’s operations have consisted primarily of providing advisory and operational services to hemp and ancillary cannabis companies, serving as a business accelerator working with startups and emerging brands nationwide. Headquartered in Seattle, Cannavolve has guided clients through every phase of the startup process, including business planning and forecasting, funding and investment, human resources and legal operations and manufacturing, and sales and marketing. Cannavolve’s go-to-market strategies and program implementation processes were designed with one goal in mind: to drive innovation and position startups for sustainable momentum and growth.

Toward the end of 2019, Cannavolve began to decrease its advisory and operational services to hemp and ancillary cannabis companies and shifted its focus to product development, brand management and creating CBD lifestyle brands. Cannavolve’s mission is now to launch and operate best-in-class brands in the Luxury, Premium and Mass Market space with an objective on innovation and product uniqueness, derived from research insights, demographic data, customer interviews and omni-channel experiences.

We value our Cannavolve customers’ personal well-being as much as we value the well-being of our planet. We believe in responsible luxury that respects nature and humankind, a luxury that prepares for a better world for future generations. We believe that ethics and moral values are becoming increasingly important for consumers in such a way that they are starting to strongly influence their purchasing decisions. Environment, sustainability, cruelty-free production and labor practices are all elements now taken into consideration when buying a product.

Our full spectrum CBD used in our products is rich in Phytocannabinoids and is THC free. Our CBD is sustainably farmed and sourced. We employ supercritical CO2 and alcohol extraction technologies without the use of any harsh chemicals. All of our CBD use in our products is tested up to 20 times through cultivation, extraction and manufacturing process to final packaged product. Our CBD is also vegan, gluten free, cruelty free and Non-GMO.

Each of our portfolio brands is planned to have its own digital architecture which will allow us to closely monitor our sales channel strategies and continually refine sales channels while exploring new ones which we believe represent the greatest potential. We intend to build brand loyalty by endorsing consumer core values of authenticity and relatability and maintain a commitment to following sustainable practices and rigorous product testing.

Principal Products and Services

The Company currently has one main product line and three in development. The Company’s current active product line is Revive Now.

Revive Now

Revive Now a mass market, premium-quality, full spectrum, hemp-based CBD product brand. Revive Now offers quality products at competitive market pricing, such as CBD-infused tinctures, softgels, creams, powders, gumdrops, and sprays. Products currently sold under the Revive Now product line include:

●

CBD-Infused Dried Fruits and Gummies

●

CBD Topicals

●

CBD Sprays

Revive Now products are indented to provide a safe and effective way to consume hemp-based CBD.

Revive Now Target Market

Our initial target demographic for the Revive Now brand is women over the age of 35. However, we intend to target the mass market with this brand, selling to potential purchasers of any income and background. We believe anyone looking for support for aches and pain, anxiety, inflammation, insomnia and depression are potential customers for the Revive Now brand. We intend to target customers who are looking for CBD infused products at affordable price points.

Future Product Lines

The Company has three product lines planned for introduction.

●

Ouevre - a next generation CBD luxury skin care line and lifestyle brand.

●

F.A.M.E. - a millennial, premium priced dual-gender lifestyle brand

●

LevelLab – a premium priced millennial fitness/wellness/performance product line

Ouevre

Oeuvre - ”A Body of Art” – with a planned launch in Fall 2020, is intended to be a next generation CBD luxury skin care line and lifestyle brand. Planned product offerings under this line include

●

Purifying Exfoliator

●

Replenishing Oil

●

Ultra-Nourishing Face Cream

●

Revitalizing Eye Cream

●

High Potency Tincture

●

CBD infused and scented candles

●

CBD infused women’s fragrance

Drawing inspiration from petals, leaves, roots, minerals and gemstones, Ouevre celebrates the artistry of well-being and beauty, inside and out. Ouevre products are non-toxic, ungendered products made with zero GMO, retinyl palmitate, petroleum, mineral oil, parabens, sulfates, and synthetic colors.

Ouevre Target Market

Ouevre is planned to be our luxury segment product line. With Ouevre, we are targeting a large and influential consumer class of the of individuals that are “HENRYs” – High-Earners-Not-Rich-Yet. They have discretionary income and are highly likely to be wealthy in the future. HENRYs earn between $100,000 and $250,000 annually. They are digitally fluent, love online shopping online, and are big discretionary spenders. Therefore, ouvreskincare.com offers inclusive, aspirationally affordable luxury products positioned for them.

We believe the benefit of onboarding this demographic to Ouevre are twofold: securing valuable present customers and building relationships and business with those most likely to be amongst the most affluent consumers in the future. By the year 2025, Millennials and Generation Z will represent more than 40% of the overall luxury goods market, according to a 2019 report published by Boston Consulting Group. We seek to target such group for the sale of our Ouevre products.

On social media, we will target the following audiences for the Ouevre brand

●

Women aged 30+

●

Luxury Skincare Enthusiasts

●

CBD Enthusiasts

●

Crystal Lovers

●

Wellness Audience

●

Makeup Artists

●

Art

●

Beauty

●

Influencers

●

Bloggers

●

Stores

LevelLab

We intend LevelLab to be a premium priced millennial fitness, wellness, and performance product line, with a planned launch of 2021. Intended products include:

●

Therapeutic recovery cream that provides heating and cooling effects to sooth pain, containing isolate hemp CBD, 100% THC free.

●

LevelLab Bundle including daily facial cleanser, hyaluronic and vitamin C moisturizer, and retinol night cream.

●

LevelLab Active Hydration – supplement for mineral replenishment and optimal hydration for before, during, and after workout.

●

LevelLab Fuel – a recovery drink containing a unique combination of CBD and amino acids.

LevelLab Target Market

We plan to target Millennials (generally ages 23 – 38 as of 2019) for our LevelLab product line. These consumers, who came of age in a hyper-connected, digital world, have unique shopping preferences, spend their time in different mediums, and respond to a different style of messaging than generations past. This evolution in consumer behavior accompanies a significant transition of purchasing power to the Millennial generation. According to the 2015 U.S. Census Bureau, Millennials accounted for more than 25% of the U.S. population, exceeding the number of baby boomers and making it the largest percentage of the workforce in the United States. Further, according to the U.S. Bureau of Labor Statistics, people born after 1981, including Millennials and Generation Z, accounted for approximately $1.7 trillion or 22% of the nation’s total consumer expenditure in 2017. We expect this number to significantly increase as Millennials enter their peak earning years and an increasing percentage of Generation Z joins the workforce.

F.A.M.E

F.A.M.E. will merge health and wellness with art and entertainment to curate unique and impactful products, content, and activities for a global community, with a planned launch of 2021. As stated in a 2017 article on the Wellness industry published by Forbes, 72% of millennials would rather spend money on experiences than on material goods. With F.A.M.E., we intend to give them both. Products and offerings under the F.A.M.E. brand name are currently under development.

F.A.M.E Target Market

The target market for F.A.M.E. is also Millennials. We intend to market F.A.M.E. to premium consumers – both male and female – in the Millennial market.

NOTE 2 – BASIS OF PRESENTATION AND GOING CONCERN

Basis of presentation

These interim consolidated financial statements of the Company and its subsidiaries are unaudited. In the opinion of management, all adjustments (consisting of normal recurring accruals) and disclosures necessary for a fair presentation of these interim condensed consolidated financial statements have been included. The results reported in the unaudited condensed consolidated financial statements for any interim periods are not necessarily indicative of the results that may be reported for the entire year. The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with the rules and regulations of the Securities and Exchange Commission and do not include all information and footnotes necessary for a complete presentation of financial statements in conformity with accounting principles generally accepted in the United States (“U.S. GAAP”). The Company’s unaudited condensed consolidated financial statements include the accounts of the Company and its subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation.

Certain information and footnote disclosures normally included in the annual consolidated financial statements prepared in accordance with U.S. GAAP have been condensed or omitted. These unaudited condensed consolidated financial statements should be read in conjunction with the Company’s audited consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2019 filed with the Securities and Exchange Commission on May 29, 2020.

Going concern

The Company currently has limited operations. These unaudited consolidated financial statements have been prepared assuming that the Company will continue as a going concern, which contemplates, among other things, the realization of assets and the satisfaction of liabilities in the normal course of business.

On April 18, 2020, the Company, through its subsidiary Jaguaring Company, entered into Paycheck Protection Program Promissory Note and Agreement with KeyBank National Association, pursuant to which the Company received loan proceeds of $231,500 (the “PPP Loan”). The PPP Loan was made under, and is subject to the terms and conditions of, the PPP which was established under the CARES Act and is administered by the U.S. Small Business Administration. The term of the PPP Loan is two years with a maturity date of April 18, 2022 and contains a favorable fixed annual interest rate of 1.00%. Payments of principal and interest on the PPP Loan will be deferred for the first six months of the term of the PPP Loan until November 18, 2020. Principal and interest are payable monthly and may be prepaid by the Company at any time prior to maturity with no prepayment penalties. Under the terms of the CARES Act, recipients can apply for and receive forgiveness for all or a portion of loans granted under the PPP. Such forgiveness will be determined, subject to limitations, based on the use of loan proceeds for certain permissible purposes as set forth in the PPP, including, but not limited to, payroll costs (as defined under the PPP) and mortgage interest, rent or utility costs (collectively, “Qualifying Expenses”), and on the maintenance of employee and compensation levels during the eight-week period following the funding of the PPP Loan. The Company has been using the proceeds of the PPP Loan, for Qualifying Expenses. However, no assurance is provided that the Company will be able to obtain forgiveness of the PPP Loan in whole or in part.

There is no assurance that the Company will ever be profitable or be able to secure funding or generate sufficient revenues to sustain operations. As such, there is substantial doubt about the Company’s ability to continue as a going concern. These unaudited condensed consolidated financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classifications of liabilities that may result should the Company be unable to continue as a going concern.

Covid-19

A novel strain of coronavirus (“Covid-19”) emerged globally in December 2019 and has been declared a pandemic. The extent to which Covid-19 will impact our customers, business, results and financial condition will depend on current and future developments, which are highly uncertain and cannot be predicted at this time. While the Company’s day-to-day operations beginning March 2020 have been impacted, we have suffered less immediate impact as most staff can work remotely and can continue to develop our product offerings.

That said, we have seen our business opportunities develop more slowly as business partners and potential customers are dealing with Covid-19 issues, working remotely and these issues are causing delays in decision making and finalization of negotiations and agreements.

As reflected in the accompanying unaudited consolidated financial statements, the Company had an accumulated deficit of $1,690,466 at September 30, 2020 and had a net loss and net cash flow used in operating activities of $552,840 and $675,974 for the nine months ended September 30, 2020, respectively. The Company has a limited operating history and its continued growth is dependent upon the continuation of selling its products; hence generating revenues and obtaining additional financing to fund future obligations and pay liabilities arising from normal business operations. In addition, the current cash balance cannot be projected to cover the operating expenses for the next twelve months from the release date of this report. These matters raise substantial doubt about the Company’s ability to continue as a going concern. The ability of the Company to continue as a going concern is dependent on the Company’s ability to raise additional capital, implement its business plan, and generate significant revenues. There are no assurances that the Company will be successful in its efforts to generate significant revenues, maintain sufficient cash balance or report profitable operations or to continue as a going concern. The Company plans on raising capital through the sale of equity or debt instruments to implement its business plan. However, there is no assurance these plans will be realized and that any additional financings will be available to the Company on satisfactory terms and conditions, if any.

The accompanying unaudited condensed consolidated financial statements do not include any adjustments related to the recoverability or classification of asset-carrying amounts or the amounts and classification of liabilities that may result should the Company be unable to continue as a going concern.

NOTE 3 - SIGNIFICANT ACCOUNTING POLICIES

Uses of estimates in the preparation of financial statements

The preparation of financial statements in conformity with generally accepted accounting principles accepted in the United States of America (“GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of net revenue and expenses during each reporting period. Actual results could differ from those estimates.

Cash

The Company considers all short-term highly liquid investments with an original maturity date of purchase of six months or less to be cash equivalents.

Revenue Recognition

During the nine months ended September 30, 2020 our revenue recognition policy was in accordance with ASC 605, “Revenue Recognition”, which requires the recognition of sales when there is evidence of a sales agreement, the delivery of goods has occurred, the sales price is fixed or determined and the collectability of revenue is reasonably assured.

On January 1, 2019, the Company adopted ASU 2014-09, “Revenue from Contracts with Customers” and all the related amendments, which are also codified into ASC 606. The adoption of this guidance did not have a material effect on the Company’s financial position, results of operations or cash flows.

Net loss per common share – basic and diluted

Authoritative guidance on Earnings per Share requires dual presentation of basic and diluted earnings or loss per share (“EPS”) for all entities with complex capital structures and requires a reconciliation of the numerator and denominator of the basic EPS computation to the numerator and denominator of the diluted EPS computation. Basic EPS excludes dilution; diluted EPS reflects the potential dilution that could occur if securities or other contracts to issue common stock were exercised or converted into common stock or resulted in the issuance of common stock that then shared in the earnings of the entity.

Basic loss per share is computed by dividing net loss applicable to common shareholders by the weighted average number of common shares outstanding during the period. Diluted loss per share reflects the potential dilution that could occur if dilutive securities and other contracts to issue common stock were exercised or converted into common stock or resulted in the issuance of common stock that then shared in the earnings of the Company, unless the effect is to reduce a loss or increase earnings per share.

Stock-based compensation

In accordance with ASC No. 718, Compensation – Stock Compensation (“ASC 718”), the Company measures the compensation costs of share-based compensation arrangements based on the grant-date fair value and recognize the costs in the financial statements over the period during which employees are required to provide services.

During the nine months ended September 30, 2020 and the year ended December 31, 2019, there were no stock based awards issued or outstanding.

Fair value of financial instruments

We value our financial assets and liabilities on a recurring basis using the fair value hierarchy established in Accounting Standards Codification (“ASC”) 820, Fair Value Measurements and Disclosures.

ASC 820 describes three levels of inputs that may be used to measure fair value, as follows:

Level 1 input, which include quoted prices in active markets for identical assets or liabilities;

Level 2 inputs, which include observable inputs other than Level 1 inputs, such as quoted prices for similar assets or liabilities; quoted prices for identical or similar assets or liabilities in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the asset or liability; and

Level 3 inputs, which include unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the underlying asset or liability. Level 3 assets and liabilities include those whose fair value measurements are determined using pricing models, discounted cash flow methodologies or similar valuation techniques, as well as significant management judgment or estimation.

Income Taxes

Deferred taxes are provided on a liability method whereby deferred tax assets are recognized for deductible temporary differences and operating loss and tax credit carry forwards and deferred tax liabilities are recognized for taxable temporary differences. Temporary differences are the differences between the reported amounts of assets and liabilities and their tax bases. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment. The U.S. federal income tax rate is 21%.

The provision for Federal income tax consists of the following September 30, 2020 and 2019:

Federal income tax attributable to:	September 30, 2020			September 30, 2019
Current operations	$	115,832		$	27,360
Less: Valuation allowance		(115,832	)		(27,360	)
Net provision for Federal income tax		-			-

The cumulative tax effect at the expected rate of 21% of significant items comprising our net deferred tax amount is as follows:

Deferred tax assets attributable to:	September 30, 2020			December 31, 2019
Net operating loss carry over	$	354,730		$	238,900
Less: Valuation allowance		(354,730	)		(238,900	)
Net deferred tax assets		-			-

NOTE 4 - ADVANCES TO SUPPLIER

Advances to supplier consist of single vendor where the company have placed an order of branded CBD products worth $308,030 on the November 11, 2019. As of September 30, 2020 the balance represents 60% of the total value of the order committed.

NOTE 5 - LOAN PAYABLE- OTHER

Since the change of control of the Company in May 2018, we have received advances from Pure Energy 714 LLC, an unaffiliated entity, with an outstanding balance of $220,804 as of December 31, 2018, at which time there was no formal arrangement between the Company and Pure Energy 714 LLC regarding the terms for repayment of these advances. Following further advances aggregating $84,128 during the year ended December 31, 2019, an amount of $240,803 was outstanding as of December 31, 2019. On March 15, 2019, specific terms were reached on $70,757 of such advances pursuant to an unsecured convertible promissory note entered into between the Company and Pure Energy 714 LLC, the terms call for repayment of the advances including interest on any unconverted principal amount at a rate of 4% per annum and a repayment date on or before August 15, 2022. Additional terms include a voluntary conversion option, pursuant to which Pure Energy 714 LLC may convert any outstanding balance at $0.05 per share into shares of common stock. On January 3, 2020, specific terms were reached on the remaining $150,046 of such advances pursuant to an unsecured demand note entered into between the Company and Pure Energy 714 LLC, the terms call for repayment of the advances including interest on any unconverted principal amount at a rate of 12% per annum and a repayment date on or before June 3, 2021 at the rate of 12% per annum. If the demand note is unpaid by June 3, 2021, default interest of 3% monthly will apply.

The Company has accrued interest of $23,236 on these notes.

NOTE 6 - COMMITMENTS AND CONTINGENCIES

COVID-19

On March 11, 2020, the World Health Organization announced that infections of the novel Coronavirus (COVID-19) had become pandemic, and on March 13, the U.S. President announced a National Emergency relating to the disease. There is a possibility of continued widespread infection in the United States and abroad, with the potential for catastrophic impact. National, state and local authorities have required or recommended social distancing and imposed or are considering quarantine and isolation measures on large portions of the population, including mandatory business closures. These measures, while intended to protect human life, are expected to have serious adverse impacts on domestic and foreign economies of uncertain severity and duration. Some economists are predicting the United States will soon enter a recession. The sweeping nature of the coronavirus pandemic makes it extremely difficult to predict how the Company’s business and operations will be affected in the longer run, but we expect that it may materially affect our business, financial condition and results of operations. The extent to which the coronavirus impacts our results will depend on future developments, which are highly uncertain and cannot be predicted, including new information which may emerge concerning the severity of the coronavirus and the actions to contain the coronavirus or treat its impact, among others. Moreover, the coronavirus outbreak has begun to have indeterminable adverse effects on general commercial activity and the world economy, and our business and results of operations could be adversely affected to the extent that this coronavirus or any other epidemic harms the global economy generally and/or the markets in which we operate specifically. Any of the foregoing factors, or other cascading effects of the coronavirus pandemic that are not currently foreseeable, could materially increase our costs, negatively impact our revenues and damage the Company’s results of operations and its liquidity position, possibly to a significant degree. The duration of any such impacts cannot be predicted.

The Company previously entered into an employment agreement with an employee effective as of February 28, 2019 (the “Employment Agreement”) pursuant to which the employee was to assist in advancing the Company’s business plan in consideration of a base salary of $10,000 per month (the “Base Salary”). On March 24, 2020, the employee provided the Company with written notice that, effective as of April 1, 2020, the employee voluntarily agreed to suspend the Base Salary indefinitely. On August 12, 2020, the employee tendered his written resignation to the Company terminating his employment with the Company and the Employment Agreement effective as of August 12, 2020. Accordingly, the Company accrued an expense of $10,000 per month until April 1, 2020 in connection with the Employment Agreement.

NOTE 7 - PREFERRED STOCK

The Company is authorized to issue 25,000,000 shares of Preferred Stock, par value $.001 per share. As of September 30, 2020, 1,000,000 shares of Series B Preferred Stock were issued and outstanding.

For five years from the date of issuance, the Series B Preferred Stock shall have the number of votes equal to fifty-one percent (51%) of the cumulative total vote of all classes of stock of the Corporation, common or preferred, whether such other class of stock is voting as a single class or the other classes of stock are voting together as a single group, and with respect to such vote, such holder shall have full voting rights and powers equal to the voting rights and powers of the holders of Common Stock, or any other class of preferred stock, and shall be entitled to notice of any stockholders’ meeting in accordance with the bylaws of the Corporation, and shall be entitled to vote, together with holders of Common Stock and any class of preferred stock entitled to vote, with respect to any question upon which holders of Common Stock or any class of preferred stock have the right to vote. After five years, the Series B Preferred Stock shall automatically, and without further action by the Corporation, be cancelled and void, and may not be reissued.

NOTE 8 - SUBSEQUENT EVENTS

The Company evaluates events and transactions occurring subsequent to the date of the condensed consolidated financial statements for matters requiring recognition or disclosure in the condensed consolidated financial statements. The accompanying condensed consolidated financial statements consider events through the date on which the condensed consolidated financial statements were available to be issued.

Impact of COVID-19 Pandemic

In December 2019, a novel coronavirus disease (“COVID-19”) was reported and in January 2020, the World Health Organization (“WHO”) declared it a Public Health Emergency of International Concern. On February 28, 2020, the WHO raised its assessment of the COVID-19 threat from high to very high at a global level due to the continued increase in the number of cases and affected countries, and on March 11, 2020, the WHO characterized COVID-19 as a pandemic.

As of the date of this filing, our primary suppliers continue to be operating. However, the broader implications of COVID-19 on our results of operations and overall financial performance remain uncertain. We may experience constrained supply or other business disruptions that could materially impact our business, results of operations and overall financial performance in future periods. See Risk Factors for further discussion of the possible impact of the COVID-19 pandemic on our business.

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The following discussion and analysis of the results of operations and financial condition of Intelligent Buying, Inc. for the nine months ended September 30, 2020 and 2019 should be read in conjunction with the Intelligent Buying, Inc. unaudited condensed consolidated financial statements and the notes thereto contained elsewhere in this report. Our discussion includes forward-looking statements based upon current expectations that involve risks and uncertainties, such as our plans, objectives, expectations and intentions. Actual results and the timing of events could differ materially from those anticipated in these forward-looking statements as a result of a number of factors, including those set forth under the Risk Factors, Special Note Regarding Forward-Looking Statements and Business sections in our Form 10-K as filed with the Securities and Exchange Commission on May 29, 2020. We use words such as “anticipate,” “estimate,” “plan,” “project,” “continuing,” “ongoing,” “expect,” “believe,” “intend,” “may,” “will,” “should,” “could,” and similar expressions to identify forward-looking statements .

Unless otherwise indicated, references to the “Company,” “us” or “we” refer to Intelligent Buying, Inc. and its subsidiaries.

Overview

In addition, on May 28, 2020, the Company entered into and closed a Share Exchange Agreement (the “Share Exchange Agreement”) with the remaining shareholders of Cannavolve (the “Remaining Cannavolve Shareholders”). Pursuant to the Share Exchange Agreement, the Company acquired an aggregate of 7,656,441 shares of common stock of Cannavolve constituting 18.5% of the issued and outstanding shares of common stock of Cannavolve from the Remaining Cannavolve Shareholders in exchange for 159,627 shares of common stock of the Company, constituting 0.02% of the issued and outstanding shares of Common Stock of the Company (the “Share Exchange”). As a result of the Share Exchange, Cannavolve is a wholly owned operating subsidiary of the Company. Additionally, on May 28, 2020, the Company’s Board of Directors (the “Board) increased the size of the Board from one to two and George Furlan was appointed as a director to fill the vacancy.

Cannavolve

Principal Products and Services

The Company currently has one main product line and three in development. The Company’s current active product line is Revive Now.

Revive Now

●

CBD-Infused Dried Fruits and Gummies

●

CBD Topicals

●

CBD Sprays

Revive Now products are indented to provide a safe and effective way to consume hemp-based CBD.

Revive Now Target Market

Future Product Lines

The Company has three product lines planned for introduction.

●

Ouevre - a next generation CBD luxury skin care line and lifestyle brand.

●

F.A.M.E. - a millennial, premium priced dual-gender lifestyle brand

●

LevelLab – a premium priced millennial fitness/wellness/performance product line

Ouevre

●

Purifying Exfoliator

●

Replenishing Oil

●

Ultra-Nourishing Face Cream

●

Revitalizing Eye Cream

●

High Potency Tincture

●

CBD infused and scented candles

●

CBD infused women’s fragrance

Ouevre Target Market

On social media, we will target the following audiences for the Ouevre brand

●

Women aged 30+

●

Luxury Skincare Enthusiasts

●

CBD Enthusiasts

●

Crystal Lovers

●

Wellness Audience

●

Makeup Artists

●

Art

●

Beauty

●

Influencers

●

Bloggers

●

Stores

LevelLab

We intend LevelLab to be a premium priced millennial fitness, wellness, and performance product line, with a planned launch of 2021. Intended products include:

●

Therapeutic recovery cream that provides heating and cooling effects to sooth pain, containing isolate hemp CBD, 100% THC free.

●

LevelLab Bundle including daily facial cleanser, hyaluronic and vitamin C moisturizer, and retinol night cream.

●

LevelLab Active Hydration – supplement for mineral replenishment and optimal hydration for before, during, and after workout.

●

LevelLab Fuel – a recovery drink containing a unique combination of CBD and amino acids.

LevelLab Target Market

F.A.M.E

F.A.M.E. will merge health and wellness with art and entertainment to curate unique and impactful products, content, and activities for a global community, with a planned launch of 2021. As stated in a 2017 article on the Wellness industry published by Forbes,, 72% of millennials would rather spend money on experiences than on material goods. With F.A.M.E., we intend to give them both. Products and offerings under the F.A.M.E. brand name are currently under development.

F.A.M.E Target Market

The target market for F.A.M.E. is also Millennials. We intend to market F.A.M.E. to premium consumers – both male and female – in the Millennial market.

RESULTS OF OPERATIONS

Comparison of Results of Operations for the Nine months Ended September 30, 2020 and 2019

Revenue

We acquired Cannavolve on February 14, 2020 where we consolidated our financial statements since then. The Company provides advisory and operational services to hemp and ancillary cannabis companies, serving as a full-service business accelerator working with startups and emerging brands nationwide. The Company accelerates customer’s businesses through a proven model of funding; operations; product launches; and ongoing sales, marketing, and expansion into new markets. Each customer arrangement is unique and revenue is recognized, both over time and at a point in time, depending upon the performance obligations stated in the contract. During the nine months ending September 30, 2020 total revenues reported was $19,219, have no revenues for the nine months period ending September 30, 2019.

Cost of Revenue

Cost of revenue includes the cost of internal labor and related benefits, travel expenses related to consulting services, subcontractor costs, other related consulting costs, and other overhead costs. During the nine months ending September 30, 2020 the cost of revenue was $9,509.

Gross Margin

Gross Profit for the nine months ending September 30, 2020 is $9,710 or 51% of total revenues. We expect to keep our gross profit at about 40% in the next quarter.

Operating Expenses

For the nine months ended September 30, 2020 and 2019, operating expenses consisted of the following:

	Nine months ended September 30,
	2020		2019
Advertising and Marketing	$	32,162	$
Selling Expenses		22,020
General and Administrative		134,544		19,459
Legal and Professional		231,133		32,758
Office rent		16,351
Management Fees		158,718		78,071
Product development cost		26,200
TOTAL OPERATING EXPENSES	$	621,128	$	130,288

	●	Our advertising and marketing mainly include consulting fees for branding, social media and creation of marketing materials for our brand.
	●	Selling expense mainly includes our marketing and sales staff’s salaries and related benefits, and travel and entertainment costs incurred by our sales department.
	●	Legal and professional fees primarily consisted of accounting fees, legal service fees, consulting fees, investor relations service charges and other fees incurred for service related to becoming and being a public company. For nine months ended September 30, 2020, professional fees increase over the same period in 2019 as mainly attributable to an increase in fees of approximately $70,000 incurred for services performed by our marketing consultant, and an increase in legal services fees of approximately $36,000. We expect professional fees to increase as we incur significant costs associated with our public company reporting requirements, and costs associated with newly applicable corporate governance requirements, including requirements under the Sarbanes-Oxley Act of 2002 and other rules implemented by the Securities and Exchange Commission.
	●	Office rent are monthly lease payments for our principal executive offices in New York.
	●	Our management fees comprise mainly of salaries paid our management staff. The nine months period ending September 30, 2020 the increase in management fee mainly attributable to the salaries of our Chief Financial Officer and directors approximately $60,000.
	●	Product development cost includes packaging supplies and materials, design and marketing consultants approximately $26,200 for the nine months period ending September 30, 2020, there were no product development cost incurred for the nine months period ending September 30, 2019.

Loss from Operations

The Company’s net loss for the nine-month period ended September 30, 2020 and 2019 was $552,840 and $130,288, respectively.

Income Taxes

We did not have any income taxes expense for the nine months ended September 30, 2020 and 2019 since we incurred losses in the periods.

Liquidity and Capital Resources

Covid 19

That said we have seen our business opportunities develop more slowly as business partners and potential customers are dealing with Covid-19 issues, working remotely and these issues are causing delays in decision making and finalization of negotiations and agreements.

Contractual Obligations and Off-Balance Sheet Arrangements

Contractual Obligations

We presently do not have any contractual obligations.

Off-balance Sheet Arrangements

We presently do not have off-balance sheet arrangements.

Inflation

The effect of inflation on our revenue and operating results was not significant.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.

As a smaller reporting company, as defined in Rule 12b-2 of the Exchange Act, we are not required to provide the information required by this Item.

ITEM 4. CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

Changes in Internal Controls over Financial Reporting

There were no changes (including corrective actions with regard to material weakness) in our internal controls over financial reporting that occurred during the period covered by this report that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

PART II - OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

From time to time, we are subject to ordinary routine litigation incidental to our normal business operations. We are not currently a party to any litigation the outcome of which, if determined adversely to us, would individually or in the aggregate be reasonably expected to have a material adverse effect on our business, operating results, cash flows or financial condition.

ITEM 1A. RISK FACTORS

Risk factors describing the major risks to our business can be found under Item 1A, “Risk Factors”, in our Annual Report on Form 10-K for the year ended December 31, 2019. There has been no material change in our risk factors from those previously discussed in the Annual Report on Form 10-K.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

On May 28, 2020, the Company entered into and closed a Share Exchange Agreement (the “Share Exchange Agreement”) with the remaining shareholders of Cannavolve (the “Cannavolve Shareholders”). Pursuant to the Share Exchange Agreement, the Company acquired an aggregate of 7,656,441 shares of common stock of Cannavolve constituting the remaining 18.5% of the issued and outstanding shares of common stock of Cannavolve from the Cannavolve Shareholders in exchange for 159,627 shares of common stock of the Company, constituting 0.02% of the issued and outstanding shares of Common Stock of the Company (the “Share Exchange”). As a result of the Share Exchange, Cannavolve is a wholly owned operating subsidiary of the Company.

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

None.

ITEM 4. MINE SAFETY DISCLOSURES

None.

ITEM 5. OTHER INFORMATION

None.

ITEM 6. EXHIBITS

The following exhibits are filed as part of, or incorporated by reference into, this Quarterly Report on Form 10-Q.

Exhibit No.		Exhibit Description

2.1		Reorganization Agreement between Intelligent Buying Inc. and Jaguaring Company d/b/a Cannavolve, and the Cannavolve shareholders listed in the agreement, dated March 13, 2019 (incorporated by reference to Exhibit 99.1 to the Company’s Current Report on Form 8-K filed with the SEC on March 19, 2019).

2.2		Amended Reorganization Agreement between Intelligent Buying Inc. and Jaguaring Company d/b/a Cannavolve and the Cannavolve shareholders listed in the agreement, dated April 27, 2019 (incorporated by reference to Exhibit 99.2 to the Company’s Current Report on Form 8-K filed with the SEC on May 6, 2019).

2.3		Amendment No. 1 to Reorganization Agreement between Intelligent Buying Inc. and Jaguaring Company d/b/a Cannavolve, and the Cannavolve shareholders listed in the agreement, dated April 27, 2019 (incorporated by reference to Exhibit 99.3 to the Company’s Current Report on Form 8-K filed with the SEC on May, 6 2019).

2.4		Second Amended Agreement and Plan of Reorganization between Intelligent Buying Inc. and Jaguaring Company d/b/a Cannavolve Holdings, the Cannavolve Shareholders listed in the agreement dated January 2, 2020 (incorporated by reference to Exhibit 99.1 to the Company’s Current Report on Form 8-K filed with the SEC on January 8, 2020).

2.5		Termination Agreement of the Reorganization between Intelligent Buying Inc. and Jaguaring Company d/b/a Cannavolve Holdings, the Cannavolve Shareholders listed in the agreement dated February 12, 2020. (Incorporated by reference to the Form 8-K Current Report filed with the Securities and Exchange Commission on February 14, 2020).

2.6		Agreement and Plan of Reorganization by and among Intelligent Buying Inc., Jaguaring Company d/b/a Cannavolve Holdings and the Cannavolve Shareholders listed in the agreement dated February 14, 2020. (Incorporated by reference to the Form 8-K Current Report filed with the Securities and Exchange Commission on February 14, 2020).

3.1		Articles of Incorporation of Intelligent Buying Inc. and Certificate of Amendment of Articles of Incorporation of Intelligent Buying, Inc. (incorporated by reference to Exhibit 3.1 to the Company’s Registration Statement on Form SB-2 filed with the SEC on April 17, 2006).

3.2		Bylaws of Intelligent Buying, Inc. (Incorporated by reference to the Form 8-K Current Report filed with the Securities and Exchange Commission on February 14, 2020).

3.3		Certificate of Determination for Series A Convertible Preferred Stock of Intelligent Buying, Inc. (incorporated by reference to Exhibit 4.2 to the Company’s Registration Statement on Form SB-2 filed with the SEC on April 17, 2006).

3.4		Certificate of Determination for Series B Preferred Stock of Intelligent Buying, Inc. (Incorporated by reference to the Form 8-K Current Report filed with the Securities and Exchange Commission on February 14, 2020).

10.1		Convertible Promissory Note of Intelligent Buying Inc. issued to PureEnergy714 LLC2019 (incorporated by reference to Exhibit 99.2 to the Company’s Current Report on Form 8-K filed with the SEC on March 19, 2019).

10.2		Convertible Promissory Note issued by Jaguaring, Inc. d/b/a Cannavolve (incorporated by reference to Exhibit 99.3 to the Company’s Current Report on Form 8-K filed with the SEC on March 19, 2019).

10.3		Form of Subscription Agreement for Rule 506 Offering. (Incorporated by reference to the Form 8-K Current Report filed with the Securities and Exchange Commission on February 14, 2020).

10.4		Executive Consulting Agreement between Intelligent Buying, Inc. and James Mansour dated January 8, 2020. (Incorporated by reference to the Form 8-K Current Report filed with the Securities and Exchange Commission on February 14, 2020).

10.5		Employment Agreement between Intelligent Buying, Inc. and George V. Furlan dated December 2019. (Incorporated by reference to the Form 8-K Current Report filed with the Securities and Exchange Commission on February 14, 2020).

10.6		Independent Contractor Agreement between Jaguaring Inc. d/b/a Cannavolve and Dante Jones dated May 1, 2019. (Incorporated by reference to the Form 8-K Current Report filed with the Securities and Exchange Commission on February 14, 2020).

10.7		Addendum to Independent Contractor Agreement between Jaguaring Inc. d/b/a Cannavolve and Dante Jones dated September 20, 2019. (Incorporated by reference to the Form 8-K Current Report filed with the Securities and Exchange Commission on February 14, 2020).

10.8		Independent Contractor Agreement between Jaguaring Inc. d/b/a Cannavolve and Eric Swaney dated May 1, 2019. (Incorporated by reference to the Form 8-K Current Report filed with the Securities and Exchange Commission on February 14, 2020).

10.9		Addendum to Independent Contractor Agreement between Jaguaring Inc. d/b/a Cannavolve and Eric Swaney dated May 1, 2019. (Incorporated by reference to the Form 8-K Current Report filed with the Securities and Exchange Commission on February 14, 2020).

10.10		Office Agreement for Jaguaring Inc. d/b/a Cannavolve dated May 23, 2018. (Incorporated by reference to the Form 8-K Current Report filed with the Securities and Exchange Commission on February 14, 2020).

10.11		Promissory Note issued by Jaguaring Inc. d/b/a Cannavolve dated June 11, 2019. (Incorporated by reference to the Form 8-K Current Report filed with the Securities and Exchange Commission on February 14, 2020).

10.12		Promissory Note issued by Jaguaring Inc. d/b/a Cannavolve dated June 6, 2019. (Incorporated by reference to the Form 8-K Current Report filed with the Securities and Exchange Commission on February 14, 2020).

10.13		Employment Agreement between Intelligent Buying, Inc. and Gregg Templeton dated February 28, 2019. (Incorporated by reference to the Form 8-K Current Report filed with the Securities and Exchange Commission on February 14, 2020).

10.14*+		Restricted Stock Purchase Agreement between Intelligent Buying, Inc. and James Mansour.

10.15*+		Restricted Stock Purchase Agreement between Intelligent Buying, Inc. and George Furlan. (Incorporated by reference to the Form 8-K Current Report filed with the Securities and Exchange Commission on February 14, 2020).

10.16		Share Exchange Agreement dated as of May 28, 2020 by and among Intelligent Buying Inc., and the shareholders of Jaguaring Company d/b/a Cannavolve Holdings. (Incorporated by reference to the Form 10-K Annual Report filed with the Securities and Exchange Commission on May 29, 2020).

14.1		Code of Ethics of Intelligent Buying, Inc. (incorporated by reference to Exhibit 14.1 to the Company’s Registration Statement on Form SB-2 filed with the SEC on April 17, 2006).

31.1*		Certification of Chief Executive Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a) as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

31.2*		Certification of Chief Financial Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a) as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

32.1*		Certification of Chief Executive Officer & Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	INTELLIGENT BUYING, INC.
	(Registrant)

Date: November 24, 2020	By:	/s/ George Furlan
		George Furlan
		Chief Executive Officer, President and Director (Principal Executive Officer)

Date: November 24, 2020	By:	/s/ George Furlan
		George Furlan
		Chief Financial Officer (Principal Financial and Accounting Officer)

EX-31.1 2 e2251_ex31-1.htm EXHIBIT 31.1

Exhibit 31.1

Certification Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

I, George Furlan, certify that:

I have reviewed this Quarterly Report on Form 10-Q/A (the “report”) of Intelligent Buying, Inc.;

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15 (e) and 15d-15 (e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15 (f) and 15d-15 (f)) for the registrant and have:

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

All significant deficiencies and material weaknesses in the design or operation of internal controls over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: November 24, 2020	By:	/s/ George Furlan
		George Furlan
		Chief Executive Officer, President and Director (Principal Executive Officer)

EX-31.2 3 e2251_ex31-2.htm EXHIBIT 31.2

Exhibit 31.2

Certification Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

I, George Furlan, certify that:

I have reviewed this Quarterly Report on Form 10-Q/A (the “report”) of Intelligent Buying, Inc.;

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: November 24, 2020	By:	/s/ George Furlan
		George Furlan
		Chief Financial Officer (Principal Financial and Accounting Officer)

EX-32.1 4 e2251_ex32-1.htm EXHIBIT 32.1

Exhibit 32.1

Certifications Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350

Certification of Chief Executive Officer and Chief Financial Officer Pursuant to 18 U.S.C. Section 1350

The undersigned, George Furlan, in his capacities as Chief Executive Officer and Chief Financial Officer, respectively, of Intelligent Buying, Inc. (the “Registrant”) does hereby certify with respect to the Quarterly Report on Form 10-Q/A of the Registrant for the period ended September 30, 2020, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), that, to the best of his knowledge:

(1)

The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant as of, and for, the periods presented in this Report.

Date: November 24, 2020	/s/ George Furlan
	George Furlan
	Chief Executive Officer, President and Director (Principal Executive Officer)


Date: November 24, 2020	/s/ George Furlan
	George Furlan
	Chief Financial Officer (Principal Financial and Accounting Officer)

EX-101.INS 5 intb-20200930.xml XBRL INSTANCE FILE 0001358633 2019-12-31 0001358633 2020-09-30 0001358633 2019-01-01 2019-09-30 0001358633 2020-01-01 2020-09-30 0001358633 2020-11-23 0001358633 us-gaap:UnsecuredDebtMember 2019-03-15 0001358633 us-gaap:UnsecuredDebtMember 2019-03-14 2019-03-15 0001358633 intb:AgreementMember intb:CannavolveMember 2020-02-01 2020-02-14 0001358633 intb:AgreementMember intb:CannavolveMember 2020-02-14 0001358633 intb:AgreementMember intb:PrincipalMember 2020-02-01 2020-02-14 0001358633 intb:AgreementMember intb:BagelHoleMember 2020-02-01 2020-02-14 0001358633 intb:AgreementMember intb:BagelHoleMember 2020-02-02 2020-02-14 0001358633 2019-11-11 0001358633 us-gaap:UnsecuredDebtMember 2020-01-03 0001358633 intb:AgreementMember intb:CannavolveMember 2020-05-01 2020-05-28 0001358633 intb:AgreementMember intb:CannavolveMember 2020-05-28 0001358633 intb:AgreementMember intb:BagelHoleMember 2020-02-03 2020-02-14 0001358633 2018-12-31 0001358633 2019-01-01 2019-12-31 0001358633 2019-09-30 0001358633 2020-07-01 2020-09-30 0001358633 2019-07-01 2019-09-30 0001358633 us-gaap:CommonStockMember 2020-01-01 2020-03-31 0001358633 us-gaap:CommonStockMember 2019-12-31 0001358633 us-gaap:CommonStockMember 2020-06-30 0001358633 us-gaap:CommonStockMember 2020-09-30 0001358633 us-gaap:CommonStockMember 2018-12-31 0001358633 us-gaap:CommonStockMember 2019-06-30 0001358633 us-gaap:CommonStockMember 2019-09-30 0001358633 us-gaap:PreferredStockMember 2020-06-30 0001358633 us-gaap:PreferredStockMember 2018-12-31 0001358633 us-gaap:PreferredStockMember 2019-06-30 0001358633 us-gaap:PreferredStockMember 2019-09-30 0001358633 us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-03-31 0001358633 us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0001358633 us-gaap:AdditionalPaidInCapitalMember 2020-06-30 0001358633 us-gaap:AdditionalPaidInCapitalMember 2020-09-30 0001358633 us-gaap:AdditionalPaidInCapitalMember 2018-12-31 0001358633 us-gaap:AdditionalPaidInCapitalMember 2019-06-30 0001358633 us-gaap:AdditionalPaidInCapitalMember 2019-09-30 0001358633 us-gaap:RetainedEarningsMember 2020-01-01 2020-03-31 0001358633 us-gaap:RetainedEarningsMember 2020-07-01 2020-09-30 0001358633 us-gaap:RetainedEarningsMember 2019-01-01 2019-03-31 0001358633 us-gaap:RetainedEarningsMember 2019-07-01 2019-09-30 0001358633 us-gaap:RetainedEarningsMember 2019-12-31 0001358633 us-gaap:RetainedEarningsMember 2020-06-30 0001358633 us-gaap:RetainedEarningsMember 2020-09-30 0001358633 us-gaap:RetainedEarningsMember 2018-12-31 0001358633 us-gaap:RetainedEarningsMember 2019-06-30 0001358633 us-gaap:RetainedEarningsMember 2019-09-30 0001358633 2020-01-01 2020-03-31 0001358633 2019-01-01 2019-03-31 0001358633 2020-06-30 0001358633 2019-06-30 0001358633 intb:AgreementMember intb:KeyBankMember 2020-04-01 2020-04-18 0001358633 us-gaap:PreferredStockMember 2020-01-01 2020-03-31 0001358633 us-gaap:PreferredStockMember 2020-09-30 0001358633 us-gaap:CommonStockMember 2020-04-01 2020-06-30 0001358633 us-gaap:CommonStockMember 2020-03-31 0001358633 us-gaap:CommonStockMember 2019-03-31 0001358633 us-gaap:PreferredStockMember 2020-03-31 0001358633 us-gaap:PreferredStockMember 2019-03-31 0001358633 us-gaap:AdditionalPaidInCapitalMember 2020-04-01 2020-06-30 0001358633 us-gaap:AdditionalPaidInCapitalMember 2020-03-31 0001358633 us-gaap:AdditionalPaidInCapitalMember 2019-03-31 0001358633 us-gaap:RetainedEarningsMember 2020-04-01 2020-06-30 0001358633 us-gaap:RetainedEarningsMember 2019-04-01 2019-06-30 0001358633 us-gaap:RetainedEarningsMember 2020-03-31 0001358633 us-gaap:RetainedEarningsMember 2019-03-31 0001358633 2020-04-01 2020-06-30 0001358633 2019-04-01 2019-06-30 0001358633 2020-03-31 0001358633 2019-03-31 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure

0.001

50000000

7975003

7254588

7975003

7254588

-130288

-552840

-22249

-44169

-362673

-22249

-49497

-44169

-362673

-49497

-167918

-36622

-167918

-36622

1000000

0.001

25000000

0.04

0.12

70757

150046

2022-08-15

0.05

Intelligent Buying, Inc. 0001358633 true --12-31 10-Q/A 2020-09-30 2020 Q3 Non-accelerated Filer true Yes false false 001-34861 Yes CA

33674262

7656441

0.815

0.185

702111

159627

0.001

1000000

4114352

667402

4114352

256500

123000

134874

308030

30000

-19999

84128

0.03

23236

10000

7254588

Uses of estimates in the preparation of financial statements   The preparation of financial statements in conformity with generally accepted accounting principles accepted in the United States of America (“GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of net revenue and expenses during each reporting period. Actual results could differ from those estimates.

Net loss per common share – basic and diluted   Authoritative guidance on Earnings per Share requires dual presentation of basic and diluted earnings or loss per share (“EPS”) for all entities with complex capital structures and requires a reconciliation of the numerator and denominator of the basic EPS computation to the numerator and denominator of the diluted EPS computation. Basic EPS excludes dilution; diluted EPS reflects the potential dilution that could occur if securities or other contracts to issue common stock were exercised or converted into common stock or resulted in the issuance of common stock that then shared in the earnings of the entity.   Basic loss per share is computed by dividing net loss applicable to common shareholders by the weighted average number of common shares outstanding during the period. Diluted loss per share reflects the potential dilution that could occur if dilutive securities and other contracts to issue common stock were exercised or converted into common stock or resulted in the issuance of common stock that then shared in the earnings of the Company, unless the effect is to reduce a loss or increase earnings per share.

Fair value of financial instruments   We value our financial assets and liabilities on a recurring basis using the fair value hierarchy established in Accounting Standards Codification (“ASC”) 820, Fair Value Measurements and Disclosures.   ASC 820 describes three levels of inputs that may be used to measure fair value, as follows:    Level 1 input, which include quoted prices in active markets for identical assets or liabilities;   Level 2 inputs, which include observable inputs other than Level 1 inputs, such as quoted prices for similar assets or liabilities; quoted prices for identical or similar assets or liabilities in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the asset or liability; and      Level 3 inputs, which include unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the underlying asset or liability. Level 3 assets and liabilities include those whose fair value measurements are determined using pricing models, discounted cash flow methodologies or similar valuation techniques, as well as significant management judgment or estimation.

231500

0.21

0.0100

27360

115832

-27360

-115832

238900

354730

Cash   The Company considers all short-term highly liquid investments with an original maturity date of purchase of six months or less to be cash equivalents.

238900

354730

149635

241768

27560

10000

17611

67500

2546

38058

12043

164224

291869

388271

597197

240803

220805

147468

119892

164224

291869

-224047

-305328

-1137626

-1690466

905604

1376884

7975

7254

1000

9509

19219

166

9710

166

130288

621128

22415

44169

26200

78071

100140

5692

31479

16351

32758

289711

11400

7000

19459

134544

5323

5690

22020

32162

7256600

7154602

7256600

-0.018

-0.077

-0.003

-0.006

58578

-130288

-611418

-22249

-44169

7975003

7254588

7256600

1000000

7094961

7256600

1000000

-224047

-305328

-118165

-248453

7975

7254

7257

1000

905604

1376884

759761

-1137626

-1668217

-1749044

-885183

-971302

-1015471

-283079

-204284

1000

7095

7257

1000

1432879

759761

-1500299

-934680

-59325

-167662

702111 1000000 702 125693 127395 1000

2532200

159627

2532

397468

400000

159

-4114353 -4114 4114 0

-55995

3056

39277

-80073

-675974

67571

-27576

-11874

17611

-7611

27560

67500

255

3765

-3056

-39277

-53129

-7190

30000

708061

471560

256500

9024

1834

53129

NOTE 1 – ORGANIZATION AND NATURE OF OPERATIONS   On February 14, 2020 (the “Closing Date”), we entered into and closed (the “Closing”) an Agreement and Plan of Reorganization (the “Agreement”) with Cannavolve and each of the 37 shareholders of Cannavolve who executed a counterpart signature to the Agreement (the “Cannavolve Shareholders”). Pursuant to the Agreement, the Company agreed to acquire an aggregate of 33,674,262 shares of common stock of Cannavolve constituting 81.5% of the issued and outstanding shares of common stock of Cannavolve from the Cannavolve Shareholders in exchange for 702,111 shares of common stock of the Company, constituting 9.6% of the issued and outstanding shares of common stock, $0.001 par value per share (the “Common Stock”), of the Company (the “Reorganization “). Pursuant to the Agreement, the Company agreed to file a Certificate of Determination with the State of California, as soon as practicable after the Closing, to create a new class of preferred stock of the Company, the Series B Preferred Stock (the “New Preferred”), and further agreed to issue, as a post-Closing covenant, 1,000,000 shares of the New Preferred to Principal Holdings, LLC (“Principal”), in consideration of Principal successfully negotiating the Agreement and performing due-diligence in connection with the Agreement. Additionally, pursuant to the Agreement, the parties agreed that the Company’s then principal shareholder, Bagel Hole Inc. (“Bagel Hole”), which is owned solely by Philip Romanzi, the Company’s Chief Executive, Chief Financial Officer, Treasurer, Secretary and sole director, would return to the Company for cancellation and retirement an aggregate of 4,114,352 shares of Common Stock owned by Bagel Hole. Additionally, pursuant to the Agreement, the parties agreed that at Closing, (i) Mr. Romanzi would resign from all executive officer and director positions with the Company, (ii) George Furlan would be appointed as the Company’s Interim Chief Executive Officer, Interim Chief Financial Officer, Interim Treasurer, Interim Secretary and Chief Operating Officer, and (iii) Dante Jones would be appointed as the Company’s sole director. Further, the parties agreed that two additional directors would be appointed to the Company’s board of directors after Closing.   At Closing pursuant to the Agreement: (i) we issued an aggregate of 702,111 shares of Common Stock to the Cannavolve Shareholders in exchange for 33,674,262 shares of Cannavolve common stock, constituting 81.5% of the issued and outstanding shares of Cannavolve, resulting in Cannavolve becoming our 81.5% owned subsidiary; (ii) Bagel Hole returned to INTB for cancellation and retirement 4,114,352 shares of Common Stock owned by Bagel Hole; (iii) Mr. Romanzi resigned from all officer and director positions with the Company; (iv) George Furlan was appointed as the Company’s Interim Chief Executive Officer, Interim Chief Financial Officer, Interim Treasurer, Interim Secretary and Chief Operating Officer; and (v) Dante Jones was appointed as the Company’s sole director. We anticipate that, in the near future, the size of the Board will be increased to three directors.    In addition, on May 28, 2020, the Company entered into and closed a Share Exchange Agreement (the “Share Exchange Agreement”) with the remaining shareholders of Cannavolve (the “Remaining Cannavolve Shareholders”). Pursuant to the Share Exchange Agreement, the Company acquired an aggregate of 7,656,441 shares of common stock of Cannavolve constituting 18.5% of the issued and outstanding shares of common stock of Cannavolve from the Remaining Cannavolve Shareholders in exchange for 159,627 shares of common stock of the Company, constituting 0.02% of the issued and outstanding shares of Common Stock of the Company and 1,000,000 shares of newly created Series B preferred stock (the “Share Exchange”). As a result of the Share Exchange, Cannavolve is a wholly owned operating subsidiary of the Company. Additionally, on May 28, 2020, the Company’s Board of Directors (the “Board) increased the size of the Board from one to two and George Furlan was appointed as a director to fill the vacancy.    The offers, sales, and issuances of the securities described above were deemed to be exempt from registration under the Securities Act in reliance on Section 4(a)(2) of the Securities Act of 1933, as amended and/or Rule 506 as promulgated under Regulation D as transactions by an issuer not involving a public offering. The recipients of securities in each of these transactions acquired the securities for investment only and not with a view to or for sale in connection with any distribution thereof and appropriate legends were affixed to the securities issued in these transactions. Each of the recipients of securities in these transactions was an accredited or sophisticated person and had adequate access, through employment, business or other relationships, to information about us.   On July 14, 2020, shareholders holding a majority of the Company’s outstanding voting stock voted in favor of the following corporate matters (the “Corporate Matters”) which relate to the approval to authorize (1) the amendment to the Company’s Restated Articles of Incorporation to effect a forward stock split of all of the outstanding shares of common stock of the Company at a ratio of seven for one (7:1) (the “Forward Split”), which such Forward Split will not impact the Company’s authorized shares of Common Stock, (2) the amendment to the Company’s Restated Articles of Incorporation to increase in the number of authorized shares of the Company’s Common Stock from 50,000,000 to 500,000,000 shares of common stock, (3) the amendment to the Company’s Restated Articles of Incorporation to effect a change of the Company’s name from Intelligent Buying, Inc. to Sentient Brands Holdings, Inc., and (4) changing the Company’s corporate domicile from California to Nevada. The Corporate Matters are not yet effective.   Cannavolve   Cannavolve was incorporated in the state of Washington on July 6, 2012. To date, Cannavolve’s operations have consisted primarily of providing advisory and operational services to hemp and ancillary cannabis companies, serving as a business accelerator working with startups and emerging brands nationwide. Headquartered in Seattle, Cannavolve has guided clients through every phase of the startup process, including business planning and forecasting, funding and investment, human resources and legal operations and manufacturing, and sales and marketing. Cannavolve’s go-to-market strategies and program implementation processes were designed with one goal in mind: to drive innovation and position startups for sustainable momentum and growth.   Toward the end of 2019, Cannavolve began to decrease its advisory and operational services to hemp and ancillary cannabis companies and shifted its focus to product development, brand management and creating CBD lifestyle brands. Cannavolve’s mission is now to launch and operate best-in-class brands in the Luxury, Premium and Mass Market space with an objective on innovation and product uniqueness, derived from research insights, demographic data, customer interviews and omni-channel experiences.   We value our Cannavolve customers’ personal well-being as much as we value the well-being of our planet. We believe in responsible luxury that respects nature and humankind, a luxury that prepares for a better world for future generations. We believe that ethics and moral values are becoming increasingly important for consumers in such a way that they are starting to strongly influence their purchasing decisions. Environment, sustainability, cruelty-free production and labor practices are all elements now taken into consideration when buying a product.   Our full spectrum CBD used in our products is rich in Phytocannabinoids and is THC free. Our CBD is sustainably farmed and sourced. We employ supercritical CO2 and alcohol extraction technologies without the use of any harsh chemicals. All of our CBD use in our products is tested up to 20 times through cultivation, extraction and manufacturing process to final packaged product. Our CBD is also vegan, gluten free, cruelty free and Non-GMO.   Each of our portfolio brands is planned to have its own digital architecture which will allow us to closely monitor our sales channel strategies and continually refine sales channels while exploring new ones which we believe represent the greatest potential. We intend to build brand loyalty by endorsing consumer core values of authenticity and relatability and maintain a commitment to following sustainable practices and rigorous product testing.   Principal Products and Services   The Company currently has one main product line and three in development. The Company’s current active product line is Revive Now.   Revive Now   Revive Now a mass market, premium-quality, full spectrum, hemp-based CBD product brand. Revive Now offers quality products at competitive market pricing, such as CBD-infused tinctures, softgels, creams, powders, gumdrops, and sprays. Products currently sold under the Revive Now product line include:   <table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="font: 12pt Times New Roman, Times, Serif; width: 24px; padding-right: 0.8pt"> </td> <td style="font: 12pt Times New Roman, Times, Serif; width: 24px; padding-right: 0.8pt">●</td> <td style="font: 12pt Times New Roman, Times, Serif; padding-right: 0.8pt">CBD-Infused Dried Fruits and Gummies</td></tr> </table>   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 24px; padding-right: 0.8pt"> </td> <td style="width: 24px; padding-right: 0.8pt">●</td> <td style="padding-right: 0.8pt">CBD Topicals</td></tr> </table>   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 24px; padding-right: 0.8pt"> </td> <td style="width: 24px; padding-right: 0.8pt">●</td> <td style="padding-right: 0.8pt">CBD Sprays</td></tr> </table>   Revive Now products are indented to provide a safe and effective way to consume hemp-based CBD.   Revive Now Target Market   Our initial target demographic for the Revive Now brand is women over the age of 35. However, we intend to target the mass market with this brand, selling to potential purchasers of any income and background. We believe anyone looking for support for aches and pain, anxiety, inflammation, insomnia and depression are potential customers for the Revive Now brand. We intend to target customers who are looking for CBD infused products at affordable price points.   Future Product Lines   The Company has three product lines planned for introduction.   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 24px; padding-right: 0.8pt"> </td> <td style="width: 24px; padding-right: 0.8pt">●</td> <td style="padding-right: 0.8pt">Ouevre - a next generation CBD luxury skin care line and lifestyle brand.</td></tr> </table>   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 24px; padding-right: 0.8pt"> </td> <td style="width: 24px; padding-right: 0.8pt">●</td> <td style="padding-right: 0.8pt">F.A.M.E. - a millennial, premium priced dual-gender lifestyle brand</td></tr> </table>   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 24px; padding-right: 0.8pt"> </td> <td style="width: 24px; padding-right: 0.8pt">●</td> <td style="padding-right: 0.8pt">LevelLab – a premium priced millennial fitness/wellness/performance product line</td></tr> </table>   Ouevre   Oeuvre - ”A Body of Art” – with a planned launch in Fall 2020, is intended to be a next generation CBD luxury skin care line and lifestyle brand. Planned product offerings under this line include   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 24px; padding-right: 0.8pt"> </td> <td style="width: 24px; padding-right: 0.8pt">●</td> <td style="padding-right: 0.8pt">Purifying Exfoliator</td></tr> </table>   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 24px; padding-right: 0.8pt"> </td> <td style="width: 24px; padding-right: 0.8pt">●</td> <td style="padding-right: 0.8pt">Replenishing Oil</td></tr> </table>   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 24px; padding-right: 0.8pt"> </td> <td style="width: 24px; padding-right: 0.8pt">●</td> <td style="padding-right: 0.8pt">Ultra-Nourishing Face Cream</td></tr> </table>   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 24px; padding-right: 0.8pt"> </td> <td style="width: 24px; padding-right: 0.8pt">●</td> <td style="padding-right: 0.8pt">Revitalizing Eye Cream</td></tr> </table>   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 24px; padding-right: 0.8pt"> </td> <td style="width: 24px; padding-right: 0.8pt">●</td> <td style="padding-right: 0.8pt">High Potency Tincture</td></tr> </table>   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 24px; padding-right: 0.8pt"> </td> <td style="width: 24px; padding-right: 0.8pt">●</td> <td style="padding-right: 0.8pt">CBD infused and scented candles</td></tr> </table>   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 24px; padding-right: 0.8pt"> </td> <td style="width: 24px; padding-right: 0.8pt">●</td> <td style="padding-right: 0.8pt">CBD infused women’s fragrance</td></tr> </table>   Drawing inspiration from petals, leaves, roots, minerals and gemstones, Ouevre celebrates the artistry of well-being and beauty, inside and out. Ouevre products are non-toxic, ungendered products made with zero GMO, retinyl palmitate, petroleum, mineral oil, parabens, sulfates, and synthetic colors.   Ouevre Target Market   Ouevre is planned to be our luxury segment product line. With Ouevre, we are targeting a large and influential consumer class of the of individuals that are “HENRYs” – High-Earners-Not-Rich-Yet. They have discretionary income and are highly likely to be wealthy in the future. HENRYs earn between $100,000 and $250,000 annually. They are digitally fluent, love online shopping online, and are big discretionary spenders. Therefore, ouvreskincare.com offers inclusive, aspirationally affordable luxury products positioned for them.   We believe the benefit of onboarding this demographic to Ouevre are twofold: securing valuable present customers and building relationships and business with those most likely to be amongst the most affluent consumers in the future. By the year 2025, Millennials and Generation Z will represent more than 40% of the overall luxury goods market, according to a 2019 report published by Boston Consulting Group. We seek to target such group for the sale of our Ouevre products. On social media, we will target the following audiences for the Ouevre brand   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 24px; padding-right: 0.8pt"> </td> <td style="width: 24px; padding-right: 0.8pt; text-align: justify">●</td> <td style="padding-right: 0.8pt; text-align: justify">Women aged 30+</td></tr> </table>   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 24px; padding-right: 0.8pt"> </td> <td style="width: 24px; padding-right: 0.8pt; text-align: justify">●</td> <td style="padding-right: 0.8pt; text-align: justify">Luxury Skincare Enthusiasts</td></tr> </table>   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 24px; padding-right: 0.8pt"> </td> <td style="width: 24px; padding-right: 0.8pt; text-align: justify">●</td> <td style="padding-right: 0.8pt; text-align: justify">CBD Enthusiasts</td></tr> </table>   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 24px; padding-right: 0.8pt"> </td> <td style="width: 24px; padding-right: 0.8pt; text-align: justify">●</td> <td style="padding-right: 0.8pt; text-align: justify">Crystal Lovers</td></tr> </table>   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 24px; padding-right: 0.8pt"> </td> <td style="width: 24px; padding-right: 0.8pt; text-align: justify">●</td> <td style="padding-right: 0.8pt; text-align: justify">Wellness Audience</td></tr> </table>   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 24px; padding-right: 0.8pt"> </td> <td style="width: 24px; padding-right: 0.8pt; text-align: justify">●</td> <td style="padding-right: 0.8pt; text-align: justify">Makeup Artists</td></tr> </table>   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 24px; padding-right: 0.8pt"> </td> <td style="width: 24px; padding-right: 0.8pt; text-align: justify">●</td> <td style="padding-right: 0.8pt; text-align: justify">Art</td></tr> </table>   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 24px; padding-right: 0.8pt"> </td> <td style="width: 24px; padding-right: 0.8pt; text-align: justify">●</td> <td style="padding-right: 0.8pt; text-align: justify">Beauty</td></tr> </table>   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 24px; padding-right: 0.8pt"> </td> <td style="width: 24px; padding-right: 0.8pt; text-align: justify">●</td> <td style="padding-right: 0.8pt; text-align: justify">Influencers</td></tr> </table>   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 24px; padding-right: 0.8pt"> </td> <td style="width: 24px; padding-right: 0.8pt; text-align: justify">●</td> <td style="padding-right: 0.8pt; text-align: justify">Bloggers</td></tr> </table>   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 24px; padding-right: 0.8pt"> </td> <td style="width: 24px; padding-right: 0.8pt; text-align: justify">●</td> <td style="padding-right: 0.8pt; text-align: justify">Stores</td></tr> </table>   LevelLab   We intend LevelLab to be a premium priced millennial fitness, wellness, and performance product line, with a planned launch of 2021. Intended products include:   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 24px; padding-right: 0.8pt"> </td> <td style="width: 24px; padding-right: 0.8pt; text-align: justify">●</td> <td style="padding-right: 0.8pt; text-align: justify">Therapeutic recovery cream that provides heating and cooling effects to sooth pain, containing isolate hemp CBD, 100% THC free.</td></tr> </table>   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 24px; padding-right: 0.8pt"> </td> <td style="width: 24px; padding-right: 0.8pt; text-align: justify">●</td> <td style="padding-right: 0.8pt; text-align: justify">LevelLab Bundle including daily facial cleanser, hyaluronic and vitamin C moisturizer, and retinol night cream.</td></tr> </table>   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 24px; padding-right: 0.8pt"> </td> <td style="width: 24px; padding-right: 0.8pt; text-align: justify">●</td> <td style="padding-right: 0.8pt; text-align: justify">LevelLab Active Hydration – supplement for mineral replenishment and optimal hydration for before, during, and after workout.</td></tr> </table>   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 24px; padding-right: 0.8pt"> </td> <td style="width: 24px; padding-right: 0.8pt; text-align: justify">●</td> <td style="padding-right: 0.8pt; text-align: justify">LevelLab Fuel – a recovery drink containing a unique combination of CBD and amino acids.</td></tr> </table>   LevelLab Target Market   We plan to target Millennials (generally ages 23 – 38 as of 2019) for our LevelLab product line. These consumers, who came of age in a hyper-connected, digital world, have unique shopping preferences, spend their time in different mediums, and respond to a different style of messaging than generations past. This evolution in consumer behavior accompanies a significant transition of purchasing power to the Millennial generation. According to the 2015 U.S. Census Bureau, Millennials accounted for more than 25% of the U.S. population, exceeding the number of baby boomers and making it the largest percentage of the workforce in the United States. Further, according to the U.S. Bureau of Labor Statistics, people born after 1981, including Millennials and Generation Z, accounted for approximately $1.7 trillion or 22% of the nation’s total consumer expenditure in 2017. We expect this number to significantly increase as Millennials enter their peak earning years and an increasing percentage of Generation Z joins the workforce.   F.A.M.E   F.A.M.E. will merge health and wellness with art and entertainment to curate unique and impactful products, content, and activities for a global community, with a planned launch of 2021. As stated in a 2017 article on the Wellness industry published by Forbes, 72% of millennials would rather spend money on experiences than on material goods. With F.A.M.E., we intend to give them both. Products and offerings under the F.A.M.E. brand name are currently under development.   F.A.M.E Target Market   The target market for F.A.M.E. is also Millennials. We intend to market F.A.M.E. to premium consumers – both male and female – in the Millennial market.

NOTE 3 - SIGNIFICANT ACCOUNTING POLICIES   Uses of estimates in the preparation of financial statements   The preparation of financial statements in conformity with generally accepted accounting principles accepted in the United States of America (“GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of net revenue and expenses during each reporting period. Actual results could differ from those estimates.   Cash   The Company considers all short-term highly liquid investments with an original maturity date of purchase of six months or less to be cash equivalents.   Revenue Recognition   During the nine months ended September 30, 2020 our revenue recognition policy was in accordance with ASC 605, “Revenue Recognition”, which requires the recognition of sales when there is evidence of a sales agreement, the delivery of goods has occurred, the sales price is fixed or determined and the collectability of revenue is reasonably assured.   On January 1, 2019, the Company adopted ASU 2014-09, “Revenue from Contracts with Customers” and all the related amendments, which are also codified into ASC 606. The adoption of this guidance did not have a material effect on the Company’s financial position, results of operations or cash flows.    Net loss per common share – basic and diluted   Authoritative guidance on Earnings per Share requires dual presentation of basic and diluted earnings or loss per share (“EPS”) for all entities with complex capital structures and requires a reconciliation of the numerator and denominator of the basic EPS computation to the numerator and denominator of the diluted EPS computation. Basic EPS excludes dilution; diluted EPS reflects the potential dilution that could occur if securities or other contracts to issue common stock were exercised or converted into common stock or resulted in the issuance of common stock that then shared in the earnings of the entity.   Basic loss per share is computed by dividing net loss applicable to common shareholders by the weighted average number of common shares outstanding during the period. Diluted loss per share reflects the potential dilution that could occur if dilutive securities and other contracts to issue common stock were exercised or converted into common stock or resulted in the issuance of common stock that then shared in the earnings of the Company, unless the effect is to reduce a loss or increase earnings per share.   Stock-based compensation   In accordance with ASC No. 718, Compensation – Stock Compensation (“ASC 718”), the Company measures the compensation costs of share-based compensation arrangements based on the grant-date fair value and recognize the costs in the financial statements over the period during which employees are required to provide services.   During the nine months ended September 30, 2020 and the year ended December 31, 2019, there were no stock based awards issued or outstanding.   Fair value of financial instruments   We value our financial assets and liabilities on a recurring basis using the fair value hierarchy established in Accounting Standards Codification (“ASC”) 820, Fair Value Measurements and Disclosures.   ASC 820 describes three levels of inputs that may be used to measure fair value, as follows:    Level 1 input, which include quoted prices in active markets for identical assets or liabilities;   Level 2 inputs, which include observable inputs other than Level 1 inputs, such as quoted prices for similar assets or liabilities; quoted prices for identical or similar assets or liabilities in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the asset or liability; and      Level 3 inputs, which include unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the underlying asset or liability. Level 3 assets and liabilities include those whose fair value measurements are determined using pricing models, discounted cash flow methodologies or similar valuation techniques, as well as significant management judgment or estimation.   Income Taxes   Deferred taxes are provided on a liability method whereby deferred tax assets are recognized for deductible temporary differences and operating loss and tax credit carry forwards and deferred tax liabilities are recognized for taxable temporary differences. Temporary differences are the differences between the reported amounts of assets and liabilities and their tax bases. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment. The U.S. federal income tax rate is 21%.   The provision for Federal income tax consists of the following September 30, 2020 and 2019:   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1pt solid">Federal income tax attributable to:</td> <td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">September 30, 2020</td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">September 30, 2019</td> <td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 78%; padding-left: 9pt">Current operations</td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 8%; text-align: right">115,832</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 8%; text-align: right">27,360</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1pt; padding-left: 9pt">Less: Valuation allowance</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right">(115,832</td> <td style="padding-bottom: 1pt">)</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right">(27,360</td> <td style="padding-bottom: 1pt">)</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 2.5pt; padding-left: 9pt">Net provision for Federal income tax</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double"> </td> <td style="border-bottom: black 2.25pt double; text-align: right">-</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double"> </td> <td style="border-bottom: black 2.25pt double; text-align: right">-</td> <td style="padding-bottom: 2.5pt"> </td></tr> </table>   The cumulative tax effect at the expected rate of 21% of significant items comprising our net deferred tax amount is as follows:   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1pt solid">Deferred tax assets attributable to:</td> <td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">September 30, 2020</td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">December 31, 2019</td> <td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 78%; padding-left: 9pt">Net operating loss carry over</td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 8%; text-align: right">354,730</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 8%; text-align: right">238,900</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1pt; padding-left: 9pt">Less: Valuation allowance</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right">(354,730</td> <td style="padding-bottom: 1pt">)</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right">(238,900</td> <td style="padding-bottom: 1pt">)</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 2.5pt; padding-left: 9pt">Net deferred tax assets</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double"> </td> <td style="border-bottom: black 2.25pt double; text-align: right">-</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double"> </td> <td style="border-bottom: black 2.25pt double; text-align: right">-</td> <td style="padding-bottom: 2.5pt"> </td></tr> </table>

NOTE 4 - ADVANCES TO SUPPLIER   Advances to supplier consist of single vendor where the company have placed an order of branded CBD products worth $308,030 on the November 11, 2019. As of September 30, 2020 the balance represents 60% of the total value of the order committed.

NOTE 5 - LOAN PAYABLE- OTHER    Since the change of control of the Company in May 2018, we have received advances from Pure Energy 714 LLC, an unaffiliated entity, with an outstanding balance of $220,804 as of December 31, 2018, at which time there was no formal arrangement between the Company and Pure Energy 714 LLC regarding the terms for repayment of these advances. Following further advances aggregating $84,128 during the year ended December 31, 2019, an amount of $240,803 was outstanding as of December 31, 2019. On March 15, 2019, specific terms were reached on $70,757 of such advances pursuant to an unsecured convertible promissory note entered into between the Company and Pure Energy 714 LLC, the terms call for repayment of the advances including interest on any unconverted principal amount at a rate of 4% per annum and a repayment date on or before August 15, 2022. Additional terms include a voluntary conversion option, pursuant to which Pure Energy 714 LLC may convert any outstanding balance at $0.05 per share into shares of common stock.  On January 3, 2020, specific terms were reached on the remaining $150,046 of such advances pursuant to an unsecured demand note entered into between the Company and Pure Energy 714 LLC, the terms call for repayment of the advances including interest on any unconverted principal amount at a rate of 12% per annum and a repayment date on or before June 3, 2021 at the rate of 12% per annum. If the demand note is unpaid by June 3, 2021, default interest of 3% monthly will apply.   The Company has accrued interest of $23,236 on these notes.

NOTE 6 - COMMITMENTS AND CONTINGENCIES   COVID-19   On March 11, 2020, the World Health Organization announced that infections of the novel Coronavirus (COVID-19) had become pandemic, and on March 13, the U.S. President announced a National Emergency relating to the disease. There is a possibility of continued widespread infection in the United States and abroad, with the potential for catastrophic impact. National, state and local authorities have required or recommended social distancing and imposed or are considering quarantine and isolation measures on large portions of the population, including mandatory business closures. These measures, while intended to protect human life, are expected to have serious adverse impacts on domestic and foreign economies of uncertain severity and duration. Some economists are predicting the United States will soon enter a recession. The sweeping nature of the coronavirus pandemic makes it extremely difficult to predict how the Company’s business and operations will be affected in the longer run, but we expect that it may materially affect our business, financial condition and results of operations. The extent to which the coronavirus impacts our results will depend on future developments, which are highly uncertain and cannot be predicted, including new information which may emerge concerning the severity of the coronavirus and the actions to contain the coronavirus or treat its impact, among others. Moreover, the coronavirus outbreak has begun to have indeterminable adverse effects on general commercial activity and the world economy, and our business and results of operations could be adversely affected to the extent that this coronavirus or any other epidemic harms the global economy generally and/or the markets in which we operate specifically. Any of the foregoing factors, or other cascading effects of the coronavirus pandemic that are not currently foreseeable, could materially increase our costs, negatively impact our revenues and damage the Company’s results of operations and its liquidity position, possibly to a significant degree. The duration of any such impacts cannot be predicted.   The Company previously entered into an employment agreement with an employee effective as of February 28, 2019 (the “Employment Agreement”) pursuant to which the employee was to assist in advancing the Company’s business plan in consideration of a base salary of $10,000 per month (the “Base Salary”). On March 24, 2020, the employee provided the Company with written notice that, effective as of April 1, 2020, the employee voluntarily agreed to suspend the Base Salary indefinitely. On August 12, 2020, the employee tendered his written resignation to the Company terminating his employment with the Company and the Employment Agreement effective as of August 12, 2020. Accordingly, the Company accrued an expense of $10,000 per month until April 1, 2020 in connection with the Employment Agreement.

NOTE 7 - PREFERRED STOCK   The Company is authorized to issue 25,000,000 shares of Preferred Stock, par value $.001 per share. As of September 30, 2020, 1,000,000 shares of Series B Preferred Stock were issued and outstanding.   For five years from the date of issuance, the Series B Preferred Stock shall have the number of votes equal to fifty-one percent (51%) of the cumulative total vote of all classes of stock of the Corporation, common or preferred, whether such other class of stock is voting as a single class or the other classes of stock are voting together as a single group, and with respect to such vote, such holder shall have full voting rights and powers equal to the voting rights and powers of the holders of Common Stock, or any other class of preferred stock, and shall be entitled to notice of any stockholders’ meeting  in accordance with the bylaws of the Corporation, and shall be entitled to vote, together with holders of Common Stock and any class of preferred stock entitled to vote, with respect to any question upon which holders of Common Stock or any class of preferred stock have the right to vote. After five years, the Series B Preferred Stock shall automatically, and without further action by the Corporation, be cancelled and void, and may not be reissued.

NOTE 8 - SUBSEQUENT EVENTS   The Company evaluates events and transactions occurring subsequent to the date of the condensed consolidated financial statements for matters requiring recognition or disclosure in the condensed consolidated financial statements. The accompanying condensed consolidated financial statements consider events through the date on which the condensed consolidated financial statements were available to be issued.   Impact of COVID-19 Pandemic   In December 2019, a novel coronavirus disease (“COVID-19”) was reported and in January 2020, the World Health Organization (“WHO”) declared it a Public Health Emergency of International Concern. On February 28, 2020, the WHO raised its assessment of the COVID-19 threat from high to very high at a global level due to the continued increase in the number of cases and affected countries, and on March 11, 2020, the WHO characterized COVID-19 as a pandemic.   As of the date of this filing, our primary suppliers continue to be operating. However, the broader implications of COVID-19 on our results of operations and overall financial performance remain uncertain. We may experience constrained supply or other business disruptions that could materially impact our business, results of operations and overall financial performance in future periods. See Risk Factors for further discussion of the possible impact of the COVID-19 pandemic on our business.

Revenue Recognition   During the nine months ended September 30, 2020 our revenue recognition policy was in accordance with ASC 605, “Revenue Recognition”, which requires the recognition of sales when there is evidence of a sales agreement, the delivery of goods has occurred, the sales price is fixed or determined and the collectability of revenue is reasonably assured.   On January 1, 2019, the Company adopted ASU 2014-09, “Revenue from Contracts with Customers” and all the related amendments, which are also codified into ASC 606. The adoption of this guidance did not have a material effect on the Company’s financial position, results of operations or cash flows.

Stock-based compensation   In accordance with ASC No. 718, Compensation – Stock Compensation (“ASC 718”), the Company measures the compensation costs of share-based compensation arrangements based on the grant-date fair value and recognize the costs in the financial statements over the period during which employees are required to provide services.   During the nine months ended September 30, 2020 and the year ended December 31, 2019, there were no stock based awards issued or outstanding.

Income Taxes   Deferred taxes are provided on a liability method whereby deferred tax assets are recognized for deductible temporary differences and operating loss and tax credit carry forwards and deferred tax liabilities are recognized for taxable temporary differences. Temporary differences are the differences between the reported amounts of assets and liabilities and their tax bases. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment. The U.S. federal income tax rate is 21%.   The provision for Federal income tax consists of the following September 30, 2020 and 2019:   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1pt solid">Federal income tax attributable to:</td> <td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">September 30, 2020</td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">September 30, 2019</td> <td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 78%; padding-left: 9pt">Current operations</td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 8%; text-align: right">115,832</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 8%; text-align: right">27,360</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1pt; padding-left: 9pt">Less: Valuation allowance</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right">(115,832</td> <td style="padding-bottom: 1pt">)</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right">(27,360</td> <td style="padding-bottom: 1pt">)</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 2.5pt; padding-left: 9pt">Net provision for Federal income tax</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double"> </td> <td style="border-bottom: black 2.25pt double; text-align: right">-</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double"> </td> <td style="border-bottom: black 2.25pt double; text-align: right">-</td> <td style="padding-bottom: 2.5pt"> </td></tr> </table>   The cumulative tax effect at the expected rate of 21% of significant items comprising our net deferred tax amount is as follows:   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1pt solid">Deferred tax assets attributable to:</td> <td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">September 30, 2020</td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">December 31, 2019</td> <td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 78%; padding-left: 9pt">Net operating loss carry over</td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 8%; text-align: right">354,730</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 8%; text-align: right">238,900</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1pt; padding-left: 9pt">Less: Valuation allowance</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right">(354,730</td> <td style="padding-bottom: 1pt">)</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right">(238,900</td> <td style="padding-bottom: 1pt">)</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 2.5pt; padding-left: 9pt">Net deferred tax assets</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double"> </td> <td style="border-bottom: black 2.25pt double; text-align: right">-</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double"> </td> <td style="border-bottom: black 2.25pt double; text-align: right">-</td> <td style="padding-bottom: 2.5pt"> </td></tr> </table>

The provision for Federal income tax consists of the following September 30, 2020 and 2019:   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1pt solid">Federal income tax attributable to:</td> <td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">September 30, 2020</td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">September 30, 2019</td> <td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 78%; padding-left: 9pt">Current operations</td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 8%; text-align: right">115,832</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 8%; text-align: right">27,360</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1pt; padding-left: 9pt">Less: Valuation allowance</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right">(115,832</td> <td style="padding-bottom: 1pt">)</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right">(27,360</td> <td style="padding-bottom: 1pt">)</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 2.5pt; padding-left: 9pt">Net provision for Federal income tax</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double"> </td> <td style="border-bottom: black 2.25pt double; text-align: right">-</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double"> </td> <td style="border-bottom: black 2.25pt double; text-align: right">-</td> <td style="padding-bottom: 2.5pt"> </td></tr> </table>

The cumulative tax effect at the expected rate of 21% of significant items comprising our net deferred tax amount is as follows:   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1pt solid">Deferred tax assets attributable to:</td> <td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">September 30, 2020</td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">December 31, 2019</td> <td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 78%; padding-left: 9pt">Net operating loss carry over</td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 8%; text-align: right">354,730</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 8%; text-align: right">238,900</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1pt; padding-left: 9pt">Less: Valuation allowance</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right">(354,730</td> <td style="padding-bottom: 1pt">)</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: black 1pt solid"> </td> <td style="border-bottom: black 1pt solid; text-align: right">(238,900</td> <td style="padding-bottom: 1pt">)</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 2.5pt; padding-left: 9pt">Net deferred tax assets</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double"> </td> <td style="border-bottom: black 2.25pt double; text-align: right">-</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double"> </td> <td style="border-bottom: black 2.25pt double; text-align: right">-</td> <td style="padding-bottom: 2.5pt"> </td></tr> </table>

240803

220804

NOTE 2 – BASIS OF PRESENTATION AND GOING CONCERN   Basis of presentation   These interim consolidated financial statements of the Company and its subsidiaries are unaudited. In the opinion of management, all adjustments (consisting of normal recurring accruals) and disclosures necessary for a fair presentation of these interim condensed consolidated financial statements have been included. The results reported in the unaudited condensed consolidated financial statements for any interim periods are not necessarily indicative of the results that may be reported for the entire year. The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with the rules and regulations of the Securities and Exchange Commission and do not include all information and footnotes necessary for a complete presentation of financial statements in conformity with accounting principles generally accepted in the United States (“U.S. GAAP”). The Company’s unaudited condensed consolidated financial statements include the accounts of the Company and its subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation.   Certain information and footnote disclosures normally included in the annual consolidated financial statements prepared in accordance with U.S. GAAP have been condensed or omitted. These unaudited condensed consolidated financial statements should be read in conjunction with the Company’s audited consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2019 filed with the Securities and Exchange Commission on May 29, 2020.   Going concern   The Company currently has limited operations. These unaudited consolidated financial statements have been prepared assuming that the Company will continue as a going concern, which contemplates, among other things, the realization of assets and the satisfaction of liabilities in the normal course of business.   On April 18, 2020, the Company, through its subsidiary Jaguaring Company, entered into Paycheck Protection Program Promissory Note and Agreement with KeyBank National Association, pursuant to which the Company received loan proceeds of $231,500 (the “PPP Loan”). The PPP Loan was made under, and is subject to the terms and conditions of, the PPP which was established under the CARES Act and is administered by the U.S. Small Business Administration. The term of the PPP Loan is two years with a maturity date of April 18, 2022 and contains a favorable fixed annual interest rate of 1.00%. Payments of principal and interest on the PPP Loan will be deferred for the first six months of the term of the PPP Loan until November 18, 2020. Principal and interest are payable monthly and may be prepaid by the Company at any time prior to maturity with no prepayment penalties. Under the terms of the CARES Act, recipients can apply for and receive forgiveness for all or a portion of loans granted under the PPP. Such forgiveness will be determined, subject to limitations, based on the use of loan proceeds for certain permissible purposes as set forth in the PPP, including, but not limited to, payroll costs (as defined under the PPP) and mortgage interest, rent or utility costs (collectively, “Qualifying Expenses”), and on the maintenance of employee and compensation levels during the eight-week period following the funding of the PPP Loan. The Company has been using the proceeds of the PPP Loan, for Qualifying Expenses. However, no assurance is provided that the Company will be able to obtain forgiveness of the PPP Loan in whole or in part.   There is no assurance that the Company will ever be profitable or be able to secure funding or generate sufficient revenues to sustain operations. As such, there is substantial doubt about the Company’s ability to continue as a going concern. These unaudited condensed consolidated financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classifications of liabilities that may result should the Company be unable to continue as a going concern.   Covid-19   A novel strain of coronavirus (“Covid-19”) emerged globally in December 2019 and has been declared a pandemic. The extent to which Covid-19 will impact our customers, business, results and financial condition will depend on current and future developments, which are highly uncertain and cannot be predicted at this time. While the Company’s day-to-day operations beginning March 2020 have been impacted, we have suffered less immediate impact as most staff can work remotely and can continue to develop our product offerings.   That said, we have seen our business opportunities develop more slowly as business partners and potential customers are dealing with Covid-19 issues, working remotely and these issues are causing delays in decision making and finalization of negotiations and agreements.   As reflected in the accompanying unaudited consolidated financial statements, the Company had an accumulated deficit of $1,690,466 at September 30, 2020 and had a net loss and net cash flow used in operating activities of $552,840 and $675,974 for the nine months ended September 30, 2020, respectively. The Company has a limited operating history and its continued growth is dependent upon the continuation of selling its products; hence generating revenues and obtaining additional financing to fund future obligations and pay liabilities arising from normal business operations. In addition, the current cash balance cannot be projected to cover the operating expenses for the next twelve months from the release date of this report.  These matters raise substantial doubt about the Company’s ability to continue as a going concern. The ability of the Company to continue as a going concern is dependent on the Company’s ability to raise additional capital, implement its business plan, and generate significant revenues. There are no assurances that the Company will be successful in its efforts to generate significant revenues, maintain sufficient cash balance or report profitable operations or to continue as a going concern. The Company plans on raising capital through the sale of equity or debt instruments to implement its business plan. However, there is no assurance these plans will be realized and that any additional financings will be available to the Company on satisfactory terms and conditions, if any.   The accompanying unaudited condensed consolidated financial statements do not include any adjustments related to the recoverability or classification of asset-carrying amounts or the amounts and classification of liabilities that may result should the Company be unable to continue as a going concern.

This amendment is being file to furnish the xbrl exhibits, no other changes were made.

EX-101.SCH 6 intb-20200930.xsd XBRL SCHEMA FILE 00000001 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - CONSOLIDATED BALANCE SHEETS (UNAUDITED) link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - UNAUDITED STATEMENTS OF OPERATIONS (UNAUDITED) link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - UNAUDITED CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY DEFICIENCY link:presentationLink link:calculationLink link:definitionLink 00000006 - Statement - UNAUDITED CONSOLIDATED STATEMENTS OF CASH FLOWS link:presentationLink link:calculationLink link:definitionLink 00000007 - Disclosure - Organization and Nature of Operations link:presentationLink link:calculationLink link:definitionLink 00000008 - Disclosure - Basis of Presentation and Going Concern link:presentationLink link:calculationLink link:definitionLink 00000009 - Disclosure - Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 00000010 - Disclosure - Advances to Supplier link:presentationLink link:calculationLink link:definitionLink 00000011 - Disclosure - Loan payable - Other link:presentationLink link:calculationLink link:definitionLink 00000012 - Disclosure - Commitments And Contingencies link:presentationLink link:calculationLink link:definitionLink 00000013 - Disclosure - Preferred Stock link:presentationLink link:calculationLink link:definitionLink 00000014 - Disclosure - Subsequent Events link:presentationLink link:calculationLink link:definitionLink 00000015 - Disclosure - Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 00000016 - Disclosure - Significant Accounting Policies (Tables) link:presentationLink link:calculationLink link:definitionLink 00000017 - Disclosure - Organization and Nature of Operations (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000018 - Disclosure - Basis of Presentation and Going Concern (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000019 - Disclosure - Significant Accounting Policies (Schedule Of Components Of Income Tax Expense Benefit) (Details) link:presentationLink link:calculationLink link:definitionLink 00000020 - Disclosure - Significant Accounting Policies (Schedule Of Deferred Tax Assets And Liabilities) (Details) link:presentationLink link:calculationLink link:definitionLink 00000021 - Disclosure - Significant Accounting Policies (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000022 - Disclosure - Advances to Supplier (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000023 - Disclosure - Loan payable - Other (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000024 - Disclosure - Commitments and Contingencies (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000025 - Disclosure - Preferred Stock (Details Narrative) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 7 intb-20200930_cal.xml XBRL CALCULATION FILE EX-101.DEF 8 intb-20200930_def.xml XBRL DEFINITION FILE EX-101.LAB 9 intb-20200930_lab.xml XBRL LABEL FILE Debt Instrument [Axis] Unsecured Convertible Promissory Note [Member] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Agreement [Member] Related Party [Axis] Cannavolve [Member] Principal [Member] Bagel Hole [Member] Equity Components [Axis] Common Stock Preferred Stock Additional Paid-In Capital Accumulated Deficit KeyBank [Member] Preferred Stock [Member] Document And Entity Information Entity Registrant Name Entity Central Index Key Amendment Flag Amendment Description Current Fiscal Year End Date Document Type Document Period End Date Document Fiscal Year Focus Document Fiscal Period Focus Entity Filer Category Entity Small Business Entity Current Reporting Status Entity File Number Entity Interactive Data Current Entity Incorporation, State or Country Code Entity Common Stock, Shares Outstanding Entity Shell Company Is Entity Emerging Growth Company? Statement of Financial Position [Abstract] Assets CURRENT ASSETS Cash Accounts Receivables Loan Receivable Investment Advances to Supplier Inventory TOTAL CURRENT ASSETS FIXED ASSETS (net of Depreciation) OTHER ASSETS Deposit TOTAL ASSETS LIABILITIES AND STOCKHOLDERS' DEFICIENCY CURRENT LIABILITIES Accounts payable and accrued expenses Loan payable - related party Loan Payable - other TOTAL CURRENT LIABILITIES STOCKHOLDERS' DEFICIENCY Preferred Stock - Par Value of $0.001; 25,000,000 shares authorized; 1,000,000 and 0 shares issued and outstanding as of September 30, 2020 and December 31, 2019 Common Stock - Par Value of $0.001; 50,000,000 shares authorized; 7,254,588 and 7,975,003 shares issued and outstanding as of September 30, 2020 and December 31, 2019 Additional paid-in capital Accumulated deficit TOTAL STOCKHOLDERS' DEFICIENCY TOTAL LIABILITIES & STOCKHOLDERS' DEFICIENCY Common stock, par value Common stock, shares authorized Common stock, shares issued Common stock, shares outstanding Preferred stock, par value Preferred stock, shares authorized Preferred stock, shares issued Preferred stock, shares outstanding Income Statement [Abstract] REVENUES: TOTAL REVENUES Cost of sales Gross Profit Operating Expenses Advertising and Marketing Selling Expenses General and Administrative Legal and Professional Office rent Management Fees Product development cost TOTAL OPERATING EXPENSES LOSS FROM OPERATIONS INCOME TAX PROVISION Other Income (Expenses) NET LOSS NET LOSS PER COMMON SHARE - BASIC AND DILUTED WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING Statement [Table] Statement [Line Items] Beginning balance, shares Beginning balance, value Share exchange, shares Share exchange, value Issuance of common stock, shares Issuance of common stock, value Adjustment to paid in capital Common stock cancelled, shares Common stock cancelled, value Net loss Ending balance, shares Ending balance, value Statement of Cash Flows [Abstract] OPERATING ACTIVITIES: Adjustments to reconcile net loss to net cash used in operating activities: Depreciation Expense Changes in operating assets and liabilities: Accounts Receivables Inventory Loan receivables Advances to supplier Accounts payable and accrued expenses NET CASH USED IN OPERATING ACTIVITIES INVESTMENT ACTIVITIES Purchase of office equipments Deposit NET CASH USED IN INVESTING ACTIVITIES FINANCING ACTIVITIES: Proceeds (Payment) of loan payable - other Proceeds from short term loan Net proceeds from issuance of common stock NET CASH PROVIDED BY FINANCING ACTIVITIES INCREASE (DECREASE) IN CASH CASH-BEGINNING OF PERIOD CASH-END OF PERIOD Supplemental disclosures of cash flow information: Interest Taxes Organization, Consolidation and Presentation of Financial Statements [Abstract] Organization and Nature of Operations Basis of Presentation and Going Concern Accounting Policies [Abstract] Significant Accounting Policies Notes to Financial Statements ADVANCES TO SUPPLIER Debt Disclosure [Abstract] LOAN PAYABLE - OTHER Commitments and Contingencies Disclosure [Abstract] COMMITMENTS AND CONTINGENCIES Equity [Abstract] Preferred Stock Subsequent Events [Abstract] SUBSEQUENT EVENTS Uses of estimates in the preparation of financial statements Cash Revenue Recognition Net loss per common share - basic and diluted Stock-based compensation Fair value of financial instruments Income taxes Significant Accounting Policies Income tax provision (benefit) at statutory rate Summary of deferred tax assets and liabilities Subsequent Event Type [Axis] Proceeds from debt Interest rate Number of stock aquired Percentage of stock aquired Number of stock exchanged Stock price Number of stock issued Number of common stock cancelled Net cash flow used in operating activities Significant Accounting Policies Schedule Of Components Of Income Tax Expense Benefit Current operations Less: Valuation allowance Net provision for Federal income tax Significant Accounting Policies Schedule Of Deferred Tax Assets And Liabilities Net operating loss carry over Less: Valuation allowance Net deferred tax assets Effective Income Tax Rate Advances to supplier Schedule of Long-term Debt Instruments [Table] Debt Instrument [Line Items] Loan Payable - other Advances Debt amount Interest rate Maturity date Conversion price Default interest Accrued interest Accrued expenses Assets, Current Assets [Default Label] Liabilities, Current Stockholders' Equity Attributable to Parent Liabilities and Equity Gross Profit Operating Expenses [Default Label] Operating Income (Loss) Shares, Outstanding Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest Increase (Decrease) in Accounts Receivable Increase (Decrease) in Inventories Increase (Decrease) in Finance Receivables Increase (Decrease) in Accounts Payable and Accrued Liabilities Payments to Acquire Property, Plant, and Equipment Payments to Acquire Other Investments Net Cash Provided by (Used in) Investing Activities Net Cash Provided by (Used in) Financing Activities Cash and Cash Equivalents, Period Increase (Decrease) Preferred Stock [Text Block] Cash and Cash Equivalents, Policy [Policy Text Block] EX-101.PRE 10 intb-20200930_pre.xml XBRL PRESENTATION FILE XML 11 R1.htm IDEA: XBRL DOCUMENT

Document and Entity Information - shares	9 Months Ended
Document and Entity Information - shares	Sep. 30, 2020	Nov. 23, 2020
Document And Entity Information
Entity Registrant Name	Intelligent Buying, Inc.
Entity Central Index Key	0001358633
Amendment Flag	true
Amendment Description	This amendment is being file to furnish the xbrl exhibits, no other changes were made.
Current Fiscal Year End Date	--12-31
Document Type	10-Q/A
Document Period End Date	Sep. 30, 2020
Document Fiscal Year Focus	2020
Document Fiscal Period Focus	Q3
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Current Reporting Status	Yes
Entity File Number	001-34861
Entity Interactive Data Current	Yes
Entity Incorporation, State or Country Code	CA
Entity Common Stock, Shares Outstanding		7,254,588
Entity Shell Company	false
Is Entity Emerging Growth Company?	false

XML 12 R2.htm IDEA: XBRL DOCUMENT

CONSOLIDATED BALANCE SHEETS (UNAUDITED) - USD ($)	Sep. 30, 2020	Dec. 31, 2019
CURRENT ASSETS
Cash	$ 1,834	$ 9,024
Accounts Receivables	67,500
Loan Receivable		17,611
Investment	10,000
Advances to Supplier	134,874	123,000
Inventory	27,560
TOTAL CURRENT ASSETS	241,768	149,635
FIXED ASSETS (net of Depreciation)	38,058	2,546
OTHER ASSETS
Deposit	12,043	12,043
TOTAL ASSETS	291,869	164,224
CURRENT LIABILITIES
Accounts payable and accrued expenses	119,892	147,468
Loan payable - related party	220,805	240,803
Loan Payable - other	256,500
TOTAL CURRENT LIABILITIES	597,197	388,271
STOCKHOLDERS' DEFICIENCY
Preferred Stock - Par Value of $0.001; 25,000,000 shares authorized; 1,000,000 and 0 shares issued and outstanding as of September 30, 2020 and December 31, 2019	1,000
Common Stock - Par Value of $0.001; 50,000,000 shares authorized; 7,254,588 and 7,975,003 shares issued and outstanding as of September 30, 2020 and December 31, 2019	7,254	7,975
Additional paid-in capital	1,376,884	905,604
Accumulated deficit	(1,690,466)	(1,137,626)
TOTAL STOCKHOLDERS' DEFICIENCY	(305,328)	(224,047)
TOTAL LIABILITIES & STOCKHOLDERS' DEFICIENCY	$ 291,869	$ 164,224

XML 13 R3.htm IDEA: XBRL DOCUMENT

CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical) - $ / shares	Sep. 30, 2020	Dec. 31, 2019
Statement of Financial Position [Abstract]
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	50,000,000	50,000,000
Common stock, shares issued	7,254,588	7,975,003
Common stock, shares outstanding	7,254,588	7,975,003
Preferred stock, par value	$ 0.001	$ 0.001
Preferred stock, shares authorized	25,000,000	25,000,000
Preferred stock, shares issued	1,000,000	0
Preferred stock, shares outstanding	1,000,000	0

XML 14 R4.htm IDEA: XBRL DOCUMENT

UNAUDITED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
REVENUES:
TOTAL REVENUES	$ 166		$ 19,219
Cost of sales			9,509
Gross Profit	166		9,710
Operating Expenses
Advertising and Marketing			32,162
Selling Expenses			22,020
General and Administrative	5,323	5,690	134,544	19,459
Legal and Professional	11,400	7,000	289,711	32,758
Office rent			16,351
Management Fees	5,692	31,479	100,140	78,071
Product development cost			26,200
TOTAL OPERATING EXPENSES	22,415	44,169	621,128	130,288
LOSS FROM OPERATIONS	(22,249)	(44,169)	(611,418)	(130,288)
INCOME TAX PROVISION
Other Income (Expenses)			58,578
NET LOSS	$ (22,249)	$ (44,169)	$ (552,840)	$ (130,288)
NET LOSS PER COMMON SHARE - BASIC AND DILUTED	$ (0.003)	$ (0.006)	$ (0.077)	$ (0.018)
WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING	7,154,602	7,256,600	7,154,602	7,256,600

XML 15 R5.htm IDEA: XBRL DOCUMENT

UNAUDITED CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY DEFICIENCY - USD ($)	Common Stock	Preferred Stock [Member]	Additional Paid-In Capital	Accumulated Deficit	Total
Beginning balance, shares at Dec. 31, 2018	7,256,600
Beginning balance, value at Dec. 31, 2018	$ 7,257		$ 759,761	$ (885,183)	$ (118,165)
Net loss				(49,497)	(49,497)
Ending balance, shares at Mar. 31, 2019	7,256,600
Ending balance, value at Mar. 31, 2019	$ 7,257		759,761	(934,680)	(167,662)
Beginning balance, shares at Dec. 31, 2018	7,256,600
Beginning balance, value at Dec. 31, 2018	$ 7,257		759,761	(885,183)	(118,165)
Net loss					(130,288)
Ending balance, shares at Sep. 30, 2019	7,256,600
Ending balance, value at Sep. 30, 2019	$ 7,257		759,761	(1,015,471)	(248,453)
Beginning balance, shares at Mar. 31, 2019	7,256,600
Beginning balance, value at Mar. 31, 2019	$ 7,257		759,761	(934,680)	(167,662)
Net loss				(36,622)	(36,622)
Ending balance, shares at Jun. 30, 2019	7,256,600
Ending balance, value at Jun. 30, 2019	$ 7,257		759,761	(971,302)	(204,284)
Net loss				(44,169)	(44,169)
Ending balance, shares at Sep. 30, 2019	7,256,600
Ending balance, value at Sep. 30, 2019	$ 7,257		759,761	(1,015,471)	(248,453)
Beginning balance, shares at Dec. 31, 2019	7,975,003
Beginning balance, value at Dec. 31, 2019	$ 7,975		905,604	(1,137,626)	(224,047)
Share exchange, shares	702,111	1,000,000
Share exchange, value	$ 702	$ 1,000	125,693		127,395
Issuance of common stock, shares	2,532,200
Issuance of common stock, value	$ 2,532		397,468		400,000
Common stock cancelled, shares	(4,114,353)
Common stock cancelled, value	$ (4,114)		4,114		0
Net loss				(362,673)	(362,673)
Ending balance, shares at Mar. 31, 2020	7,094,961	1,000,000
Ending balance, value at Mar. 31, 2020	$ 7,095	$ 1,000	1,432,879	(1,500,299)	(59,325)
Beginning balance, shares at Dec. 31, 2019	7,975,003
Beginning balance, value at Dec. 31, 2019	$ 7,975		905,604	(1,137,626)	(224,047)
Net loss					(552,840)
Ending balance, shares at Sep. 30, 2020	7,254,588	1,000,000
Ending balance, value at Sep. 30, 2020	$ 7,254	$ 1,000	1,376,884	(1,749,044)	(305,328)
Beginning balance, shares at Mar. 31, 2020	7,094,961	1,000,000
Beginning balance, value at Mar. 31, 2020	$ 7,095	$ 1,000	1,432,879	(1,500,299)	(59,325)
Issuance of common stock, shares	159,627
Issuance of common stock, value	$ 159				159
Adjustment to paid in capital			(55,995)		(55,995)
Net loss				(167,918)	(167,918)
Ending balance, shares at Jun. 30, 2020	7,254,588	1,000,000
Ending balance, value at Jun. 30, 2020	$ 7,254	$ 1,000	1,376,884	(1,668,217)	(283,079)
Net loss				(22,249)	(22,249)
Ending balance, shares at Sep. 30, 2020	7,254,588	1,000,000
Ending balance, value at Sep. 30, 2020	$ 7,254	$ 1,000	$ 1,376,884	$ (1,749,044)	$ (305,328)

XML 16 R6.htm IDEA: XBRL DOCUMENT

UNAUDITED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019
OPERATING ACTIVITIES:
Net loss	$ (552,840)	$ (130,288)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation Expense	3,765	255
Changes in operating assets and liabilities:
Accounts Receivables	(67,500)
Inventory	(27,560)
Loan receivables	7,611	(17,611)
Advances to supplier	(11,874)
Accounts payable and accrued expenses	(27,576)	67,571
NET CASH USED IN OPERATING ACTIVITIES	(675,974)	(80,073)
INVESTMENT ACTIVITIES
Purchase of office equipments	(39,277)	(3,056)
NET CASH USED IN INVESTING ACTIVITIES	(39,277)	(3,056)
FINANCING ACTIVITIES:
Proceeds (Payment) of loan payable - other	(19,999)	30,000
Proceeds from short term loan	256,500
Net proceeds from issuance of common stock	471,560
NET CASH PROVIDED BY FINANCING ACTIVITIES	708,061	30,000
INCREASE (DECREASE) IN CASH	(7,190)	(53,129)
CASH-BEGINNING OF PERIOD	9,024	53,129
CASH-END OF PERIOD	$ 1,834
Supplemental disclosures of cash flow information:
Taxes

XML 17 R7.htm IDEA: XBRL DOCUMENT

Organization and Nature of Operations

9 Months Ended

Sep. 30, 2020

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Organization and Nature of Operations

NOTE 1 – ORGANIZATION AND NATURE OF OPERATIONS

Cannavolve

Principal Products and Services

The Company currently has one main product line and three in development. The Company’s current active product line is Revive Now.

Revive Now

●

CBD-Infused Dried Fruits and Gummies

●

CBD Topicals

●

CBD Sprays

Revive Now products are indented to provide a safe and effective way to consume hemp-based CBD.

Revive Now Target Market

Future Product Lines

The Company has three product lines planned for introduction.

●

Ouevre - a next generation CBD luxury skin care line and lifestyle brand.

●

F.A.M.E. - a millennial, premium priced dual-gender lifestyle brand

●

LevelLab – a premium priced millennial fitness/wellness/performance product line

Ouevre

●

Purifying Exfoliator

●

Replenishing Oil

●

Ultra-Nourishing Face Cream

●

Revitalizing Eye Cream

●

High Potency Tincture

●

CBD infused and scented candles

●

CBD infused women’s fragrance

Ouevre Target Market

On social media, we will target the following audiences for the Ouevre brand

●

Women aged 30+

●

Luxury Skincare Enthusiasts

●

CBD Enthusiasts

●

Crystal Lovers

●

Wellness Audience

●

Makeup Artists

●

Art

●

Beauty

●

Influencers

●

Bloggers

●

Stores

LevelLab

We intend LevelLab to be a premium priced millennial fitness, wellness, and performance product line, with a planned launch of 2021. Intended products include:

●

Therapeutic recovery cream that provides heating and cooling effects to sooth pain, containing isolate hemp CBD, 100% THC free.

●

LevelLab Bundle including daily facial cleanser, hyaluronic and vitamin C moisturizer, and retinol night cream.

●

LevelLab Active Hydration – supplement for mineral replenishment and optimal hydration for before, during, and after workout.

●

LevelLab Fuel – a recovery drink containing a unique combination of CBD and amino acids.

LevelLab Target Market

F.A.M.E

F.A.M.E Target Market

The target market for F.A.M.E. is also Millennials. We intend to market F.A.M.E. to premium consumers – both male and female – in the Millennial market.

XML 18 R8.htm IDEA: XBRL DOCUMENT

Basis of Presentation and Going Concern

9 Months Ended

Sep. 30, 2020

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Basis of Presentation and Going Concern

NOTE 2 – BASIS OF PRESENTATION AND GOING CONCERN

Basis of presentation

Going concern

Covid-19

XML 19 R9.htm IDEA: XBRL DOCUMENT

Significant Accounting Policies

9 Months Ended

Sep. 30, 2020

Accounting Policies [Abstract]

Significant Accounting Policies

NOTE 3 - SIGNIFICANT ACCOUNTING POLICIES

Uses of estimates in the preparation of financial statements

Cash

The Company considers all short-term highly liquid investments with an original maturity date of purchase of six months or less to be cash equivalents.

Revenue Recognition

Net loss per common share – basic and diluted

Stock-based compensation

During the nine months ended September 30, 2020 and the year ended December 31, 2019, there were no stock based awards issued or outstanding.

Fair value of financial instruments

ASC 820 describes three levels of inputs that may be used to measure fair value, as follows:

Level 1 input, which include quoted prices in active markets for identical assets or liabilities;

Income Taxes

The provision for Federal income tax consists of the following September 30, 2020 and 2019:

Federal income tax attributable to:	September 30, 2020			September 30, 2019
Current operations	$	115,832		$	27,360
Less: Valuation allowance		(115,832	)		(27,360	)
Net provision for Federal income tax		-			-

The cumulative tax effect at the expected rate of 21% of significant items comprising our net deferred tax amount is as follows:

Deferred tax assets attributable to:	September 30, 2020			December 31, 2019
Net operating loss carry over	$	354,730		$	238,900
Less: Valuation allowance		(354,730	)		(238,900	)
Net deferred tax assets		-			-

XML 20 R10.htm IDEA: XBRL DOCUMENT

Advances to Supplier

9 Months Ended

Sep. 30, 2020

Notes to Financial Statements

ADVANCES TO SUPPLIER

NOTE 4 - ADVANCES TO SUPPLIER

XML 21 R11.htm IDEA: XBRL DOCUMENT

Loan payable - Other

9 Months Ended

Sep. 30, 2020

Debt Disclosure [Abstract]

LOAN PAYABLE - OTHER

NOTE 5 - LOAN PAYABLE- OTHER

The Company has accrued interest of $23,236 on these notes.

XML 22 R12.htm IDEA: XBRL DOCUMENT

Commitments And Contingencies

9 Months Ended

Sep. 30, 2020

Commitments and Contingencies Disclosure [Abstract]

COMMITMENTS AND CONTINGENCIES

NOTE 6 - COMMITMENTS AND CONTINGENCIES

COVID-19

XML 23 R13.htm IDEA: XBRL DOCUMENT

Preferred Stock

9 Months Ended

Sep. 30, 2020

Equity [Abstract]

Preferred Stock

NOTE 7 - PREFERRED STOCK

The Company is authorized to issue 25,000,000 shares of Preferred Stock, par value $.001 per share. As of September 30, 2020, 1,000,000 shares of Series B Preferred Stock were issued and outstanding.

XML 24 R14.htm IDEA: XBRL DOCUMENT

Subsequent Events

9 Months Ended

Sep. 30, 2020

Subsequent Events [Abstract]

SUBSEQUENT EVENTS

NOTE 8 - SUBSEQUENT EVENTS

Impact of COVID-19 Pandemic

XML 25 R15.htm IDEA: XBRL DOCUMENT

Significant Accounting Policies (Policies)

9 Months Ended

Sep. 30, 2020

Accounting Policies [Abstract]

Uses of estimates in the preparation of financial statements

Uses of estimates in the preparation of financial statements

Cash

Cash

The Company considers all short-term highly liquid investments with an original maturity date of purchase of six months or less to be cash equivalents.

Revenue Recognition

Revenue Recognition

Net loss per common share - basic and diluted

Net loss per common share – basic and diluted

Stock-based compensation

Stock-based compensation

During the nine months ended September 30, 2020 and the year ended December 31, 2019, there were no stock based awards issued or outstanding.

Fair value of financial instruments

Fair value of financial instruments

ASC 820 describes three levels of inputs that may be used to measure fair value, as follows:

Level 1 input, which include quoted prices in active markets for identical assets or liabilities;

Income taxes

Income Taxes

The provision for Federal income tax consists of the following September 30, 2020 and 2019:

Federal income tax attributable to:	September 30, 2020			September 30, 2019
Current operations	$	115,832		$	27,360
Less: Valuation allowance		(115,832	)		(27,360	)
Net provision for Federal income tax		-			-

The cumulative tax effect at the expected rate of 21% of significant items comprising our net deferred tax amount is as follows:

Deferred tax assets attributable to:	September 30, 2020			December 31, 2019
Net operating loss carry over	$	354,730		$	238,900
Less: Valuation allowance		(354,730	)		(238,900	)
Net deferred tax assets		-			-

- Definition

Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 45
-Paragraph 25
-URI http://asc.fasb.org/extlink&oid=120406818&loc=d3e32247-109318

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 20
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32847-109319

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 954
-SubTopic 740
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6491622&loc=d3e9504-115650

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=84158767&loc=d3e18780-107790

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 19
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32840-109319

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=116657188&loc=SL116659661-227067

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 9
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 45
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=120406818&loc=d3e32280-109318

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 17
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32809-109319

+ Details

XML 26 R16.htm IDEA: XBRL DOCUMENT

Significant Accounting Policies (Tables)

9 Months Ended

Sep. 30, 2020

Significant Accounting Policies Tables Abstract

Income tax provision (benefit) at statutory rate

The provision for Federal income tax consists of the following September 30, 2020 and 2019:

Federal income tax attributable to:	September 30, 2020			September 30, 2019
Current operations	$	115,832		$	27,360
Less: Valuation allowance		(115,832	)		(27,360	)
Net provision for Federal income tax		-			-

Summary of deferred tax assets and liabilities

The cumulative tax effect at the expected rate of 21% of significant items comprising our net deferred tax amount is as follows:

Deferred tax assets attributable to:	September 30, 2020			December 31, 2019
Net operating loss carry over	$	354,730		$	238,900
Less: Valuation allowance		(354,730	)		(238,900	)
Net deferred tax assets		-			-

XML 27 R17.htm IDEA: XBRL DOCUMENT

Organization and Nature of Operations (Details Narrative) - Agreement [Member] - $ / shares			1 Months Ended
	Feb. 14, 2020	Feb. 14, 2020	May 28, 2020	Feb. 14, 2020
Cannavolve [Member]
Number of stock aquired			7,656,441	33,674,262
Percentage of stock aquired	81.50%	81.50%	18.50%	81.50%
Number of stock exchanged			159,627	702,111
Stock price	$ 0.001	$ 0.001		$ 0.001
Principal [Member]
Number of stock issued				1,000,000
Bagel Hole [Member]
Number of common stock cancelled	667,402	4,114,352		4,114,352

XML 28 R18.htm IDEA: XBRL DOCUMENT

Basis of Presentation and Going Concern (Details Narrative) - USD ($)	1 Months Ended	3 Months Ended						9 Months Ended
	Apr. 18, 2020	Sep. 30, 2020	Jun. 30, 2020	Mar. 31, 2020	Sep. 30, 2019	Jun. 30, 2019	Mar. 31, 2019	Sep. 30, 2020	Sep. 30, 2019	Dec. 31, 2019
Accumulated deficit		$ (1,690,466)						$ (1,690,466)		$ (1,137,626)
Net loss		$ (22,249)	$ (167,918)	$ (362,673)	$ (44,169)	$ (36,622)	$ (49,497)	(552,840)	$ (130,288)
Net cash flow used in operating activities								$ (675,974)	$ (80,073)
Agreement [Member] \| KeyBank [Member]
Proceeds from debt	$ 231,500
Interest rate	1.00%

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1A
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(22))
-URI http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22595-107794

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1B
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599

Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(18))
-URI http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263

Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(20))
-URI http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227

Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (b)(2)
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 9
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22663-107794

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 28
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22583-107794

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 60B
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22658-107794

+ Details

XML 29 R19.htm IDEA: XBRL DOCUMENT

Significant Accounting Policies (Schedule Of Components Of Income Tax Expense Benefit) (Details) - USD ($)	9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019
Significant Accounting Policies Schedule Of Components Of Income Tax Expense Benefit
Current operations	$ 115,832	$ 27,360
Less: Valuation allowance	(115,832)	(27,360)
Net provision for Federal income tax

XML 30 R20.htm IDEA: XBRL DOCUMENT

Significant Accounting Policies (Schedule Of Deferred Tax Assets And Liabilities) (Details) - USD ($)	Sep. 30, 2020	Dec. 31, 2019
Significant Accounting Policies Schedule Of Deferred Tax Assets And Liabilities
Net operating loss carry over	$ 354,730	$ 238,900
Less: Valuation allowance	(354,730)	(238,900)
Net deferred tax assets

XML 31 R21.htm IDEA: XBRL DOCUMENT

Significant Accounting Policies (Details Narrative)	9 Months Ended
Significant Accounting Policies (Details Narrative)	Sep. 30, 2020
Accounting Policies [Abstract]
Effective Income Tax Rate	21.00%

XML 32 R22.htm IDEA: XBRL DOCUMENT

Advances to Supplier (Details Narrative) - USD ($)	Sep. 30, 2020	Dec. 31, 2019	Nov. 11, 2019
Notes to Financial Statements
Advances to supplier	$ 134,874	$ 123,000	$ 308,030

XML 33 R23.htm IDEA: XBRL DOCUMENT

Loan payable - Other (Details Narrative) - USD ($)		9 Months Ended		12 Months Ended
Loan payable - Other (Details Narrative) - USD ($)	Mar. 15, 2019	Sep. 30, 2020	Sep. 30, 2019	Dec. 31, 2019	Jan. 03, 2020	Dec. 31, 2018
Debt Instrument [Line Items]
Loan Payable - other				$ 240,803		$ 220,804
Advances		$ (19,999)	$ 30,000	$ 84,128
Unsecured Convertible Promissory Note [Member]
Debt Instrument [Line Items]
Debt amount	$ 70,757				$ 150,046
Interest rate	4.00%				12.00%
Maturity date	Aug. 15, 2022
Conversion price	$ 0.05
Default interest					3.00%
Accrued interest					$ 23,236

XML 34 R24.htm IDEA: XBRL DOCUMENT

Commitments and Contingencies (Details Narrative)	Sep. 30, 2020 USD ($)
Commitments and Contingencies Disclosure [Abstract]
Accrued expenses	$ 10,000

XML 35 R25.htm IDEA: XBRL DOCUMENT

Preferred Stock (Details Narrative) - $ / shares	Sep. 30, 2020	Dec. 31, 2019
Equity [Abstract]
Preferred stock, par value	$ 0.001	$ 0.001
Preferred stock, shares authorized	25,000,000	25,000,000
Preferred stock, shares issued	1,000,000	0
Preferred stock, shares outstanding	1,000,000	0

EXCEL 36 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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